<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005532.pub2" GROUP_ID="ARI" ID="946705021816172400" MERGED_FROM="" MODIFIED="2013-08-07 10:47:01 +0100" MODIFIED_BY="Liz Dooley" REVIEW_NO="A105" REVMAN_SUB_VERSION="5.2.6 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.4">
<COVER_SHEET MODIFIED="2013-08-07 10:47:01 +0100" MODIFIED_BY="Liz Dooley">
<TITLE>Vitamin C for preventing and treating pneumonia</TITLE>
<CONTACT MODIFIED="2013-08-07 10:47:01 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="B45E8D7D82E26AA2000223243A3234EC" ROLE="AUTHOR"><FIRST_NAME>Harri</FIRST_NAME><LAST_NAME>Hemilä</LAST_NAME><SUFFIX>PhD, MD</SUFFIX><POSITION>Docent, Associate Professor</POSITION><EMAIL_1>harri.hemila@helsinki.fi</EMAIL_1><URL>www.ltdk.helsinki.fi/users/hemila/</URL><MOBILE_PHONE>+358 9 041 532 9987</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Public Health, POB 41</DEPARTMENT><ORGANISATION>University of Helsinki</ORGANISATION><ADDRESS_1>Mannerheimintie 172</ADDRESS_1><CITY>Helsinki</CITY><ZIP>FIN-00014</ZIP><COUNTRY CODE="FI">Finland</COUNTRY><PHONE_1>+358 9 191 27573</PHONE_1><FAX_1>+358 9 191 27570</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-08-07 10:47:01 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="B45E8D7D82E26AA2000223243A3234EC" ROLE="AUTHOR"><FIRST_NAME>Harri</FIRST_NAME><LAST_NAME>Hemilä</LAST_NAME><SUFFIX>PhD, MD</SUFFIX><POSITION>Docent, Associate Professor</POSITION><EMAIL_1>harri.hemila@helsinki.fi</EMAIL_1><URL>www.ltdk.helsinki.fi/users/hemila/</URL><MOBILE_PHONE>+358 9 041 532 9987</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Public Health, POB 41</DEPARTMENT><ORGANISATION>University of Helsinki</ORGANISATION><ADDRESS_1>Mannerheimintie 172</ADDRESS_1><CITY>Helsinki</CITY><ZIP>FIN-00014</ZIP><COUNTRY CODE="FI">Finland</COUNTRY><PHONE_1>+358 9 191 27573</PHONE_1><FAX_1>+358 9 191 27570</FAX_1></ADDRESS></PERSON><PERSON ID="859F2BF382E26AA20029B85481F1E5D4" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Pekka</FIRST_NAME><LAST_NAME>Louhiala</LAST_NAME><POSITION>Senior Lecturer</POSITION><EMAIL_1>pekka.louhiala@helsinki.fi</EMAIL_1><ADDRESS><DEPARTMENT>Department of Public Health, POB 41</DEPARTMENT><ORGANISATION>University of Helsinki</ORGANISATION><ADDRESS_1>Mannerheimintie 172</ADDRESS_1><CITY>Helsinki</CITY><ZIP>FIN-00014</ZIP><COUNTRY CODE="FI">Finland</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-06-27 13:32:35 +1000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="8" MONTH="4" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="8" MONTH="4" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="8" MONTH="4" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2013-06-27 13:42:41 +1000" MODIFIED_BY="Harri Hemilä">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-06-27 13:42:41 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="4" YEAR="2013"/>
<DESCRIPTION>
<P>Searches conducted. No new trials identified from the searches but an older study (<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK>) was included. We excluded two new trials (<LINK REF="STD-Cook-2007" TYPE="STUDY">Cook 2007</LINK>; <LINK REF="STD-Sesso-2008" TYPE="STUDY">Sesso 2008</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-06-27 13:33:49 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="4" YEAR="2013"/>
<DESCRIPTION>
<P>Our conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-04-16 03:32:46 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-04-16 03:32:46 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="2" YEAR="2011"/>
<DESCRIPTION>
<P>Searches conducted. No new trials were included in this update. Three new studies were excluded (<LINK REF="STD-Kahn-2011" TYPE="STUDY">Kahn 2011</LINK>; <LINK REF="STD-Mochalkin-1975" TYPE="STUDY">Mochalkin 1975</LINK>; <LINK REF="STD-Wahed-2008" TYPE="STUDY">Wahed 2008</LINK>). The conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-03-09 13:18:48 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="1" YEAR="2009"/>
<DESCRIPTION>
<P>Searches conducted and minor changes made to the text. Conclusions remain unchanged. No new trials found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-27 15:22:49 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="26" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-02-27 15:24:42 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="9" MONTH="2" YEAR="2006"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-04-16 05:24:31 +1000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2013-04-16 05:24:31 +1000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2013-04-16 05:24:31 +1000" MODIFIED_BY="[Empty name]">
<NAME>New Source of support</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-08-07 19:41:57 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-08-07 17:56:21 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-04-01 04:18:23 +1000" MODIFIED_BY="Jenny Bellorini">Vitamin C for preventing and treating pneumonia</TITLE>
<SUMMARY_BODY MODIFIED="2013-08-07 17:56:21 +1000" MODIFIED_BY="[Empty name]">
<P>Pneumonia is an infection of the lungs usually caused by bacteria and viruses. Its clinical diagnosis is sometimes difficult. Pneumonia is more common in young children and in the aged. In low-income countries it causes two million deaths annually among young children. In the USA it is the most common cause of death from infection.</P>
<P>Vitamin C was identified in the early 1900s and suggestions that one of its biological roles may be to resist infections are supported by numerous animal studies. We looked for studies in humans and found three trials with a total of 2335 participants that looked at whether vitamin C prevents pneumonia in the community. Two of these preventive trials studied soldiers while the third studied boys in a UK boarding school in the 1940s. Two therapeutic trials with a total of 197 pneumonia patients looked at whether vitamin C might be beneficial for pneumonia patients. One studied patients aged 66 to 94 years in the UK with pneumonia. The other therapeutic trial was conducted in the former Soviet Union but the social and nutritional backgrounds of the patients were not described. One study with 37 burns patients examined the effect of vitamin C on hospital-acquired pneumonia. Our searches were up-date-as of April 2013.</P>
<P>Five of the identified trials found preventive or therapeutic benefits of vitamin C against pneumonia but the study on hospital-acquired pneumonia found no effect. The overall quality of the studies was good. However, the five trials with positive findings were carried out in such extraordinary conditions that the results should not be extrapolated to the general population. Therefore, more research is needed. In the meantime, supplementing pneumonia patients who have low plasma vitamin C levels may be reasonable because of its safety and low cost. None of the five trials reported noteworthy adverse effects of vitamin C.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Pneumonia is one of the most common serious infections, causing two million deaths annually among young children in low-income countries. In high-income countries pneumonia is most significantly a problem of the elderly.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-06-27 13:34:35 +1000" MODIFIED_BY="[Empty name]">
<P>To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-08-05 01:34:26 +1000" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL 2013, Issue 3, MEDLINE (1950 to March week 4, 2013), EMBASE (1974 to April 2013) and Web of Science (1955 to April 2013).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>To assess the therapeutic effects of vitamin C, we selected placebo-controlled trials. To assess prophylactic effects, we selected controlled trials with or without a placebo.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two review authors independently read the trial reports and extracted data. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Liz Dooley">
<P>We identified three prophylactic trials which recorded 37 cases of community-acquired pneumonia in 2335 people. Only one was satisfactorily randomised, double-blind and placebo-controlled. Two trials examined military recruits and the third studied boys from "lower wage-earning classes" attending a boarding school in the UK during World War II. Each of these three trials found a statistically significant (80% or greater) reduction in pneumonia incidence in the vitamin C group. We identified two therapeutic trials involving 197 community-acquired pneumonia patients. Only one was satisfactorily randomised, double-blind and placebo-controlled. That trial studied elderly patients in the UK and found lower mortality and reduced severity in the vitamin C group; however, the benefit was restricted to the most ill patients. The other therapeutic trial studied adults with a wide age range in the former Soviet Union and found a dose-dependent reduction in the duration of pneumonia with two vitamin C doses. We identified one prophylactic trial recording 13 cases of hospital-acquired pneumonia in 37 severely burned patients; one-day administration of vitamin C had no effect on pneumonia incidence. The identified studies are clinically heterogeneous which limits their comparability. The included studies did not find adverse effects of vitamin C.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>The prophylactic use of vitamin C to prevent pneumonia should be further investigated in populations who have a high incidence of pneumonia, especially if dietary vitamin C intake is low. Similarly, the therapeutic effects of vitamin C should be studied, especially in patients with low plasma vitamin C levels. The current evidence is too weak to advocate prophylactic use of vitamin C to prevent pneumonia in the general population. Nevertheless, therapeutic vitamin C supplementation may be reasonable for pneumonia patients who have low vitamin C plasma levels because its cost and risks are low.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-08-07 19:41:57 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-08-07 19:33:41 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-08-06 20:11:55 +1000" MODIFIED_BY="Harri Hemilä">
<P>Pneumonia is an infection of the lungs and can be caused by bacteria, viruses, Rickettsia, fungi or parasites. Nearly 100 species have been identified as aetiological agents (<LINK REF="REF-Mandell-2010" TYPE="REFERENCE">Mandell 2010</LINK>; <LINK REF="REF-File-2003" TYPE="REFERENCE">File 2003</LINK>; <LINK REF="REF-Ruuskanen-2011" TYPE="REFERENCE">Ruuskanen 2011</LINK>). Although the pathological definition of pneumonia is clear, the clinical diagnosis is sometimes ambiguous (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</P>
<P>The risk of pneumonia is increased in young children and the elderly. In low-income countries, pneumonia causes two million deaths annually among children under five years of age (<LINK REF="REF-Mizgerd-2006" TYPE="REFERENCE">Mizgerd 2006</LINK>; <LINK REF="REF-Paynter-2010" TYPE="REFERENCE">Paynter 2010</LINK>; <LINK REF="REF-Walker-2013" TYPE="REFERENCE">Walker 2013</LINK>). In the USA, pneumonia is the sixth most common cause of death and the most common cause of infection-related deaths (<LINK REF="REF-Mandell-2010" TYPE="REFERENCE">Mandell 2010</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-08-07 19:33:41 +1000" MODIFIED_BY="[Empty name]">
<P>Vitamin C was identified in the 1930s as consequence of the search for a substance, the deficiency of which causes scurvy. After its identification there was much interest in its effects on diseases unrelated to scurvy but this role remains unclear.</P>
<P>According to systematic reviews, over two dozen controlled trials have shown that vitamin C shortens the duration of colds (<LINK REF="REF-Hemil_x00e4_-2003" TYPE="REFERENCE">Hemilä 2003</LINK>; <LINK REF="REF-Hemil_x00e4_-2013a" TYPE="REFERENCE">Hemilä 2013a</LINK>). Five trials have found that vitamin C halved the incidence of colds in participants who endured heavy acute physical stress (<LINK REF="REF-Hemil_x00e4_-1996" TYPE="REFERENCE">Hemilä 1996</LINK>; <LINK REF="REF-Hemil_x00e4_-2013a" TYPE="REFERENCE">Hemilä 2013a</LINK>), three trials have found that vitamin C halved the exercise-induced decline in forced expiratory volume in one second (FEV<SUB>1</SUB>) in participants who suffered from exercise-induced bronchoconstriction (<LINK REF="REF-Hemil_x00e4_-2013b" TYPE="REFERENCE">Hemilä 2013b</LINK>) and one trial has reported a significant decrease in the tetanus case-fatality rate (<LINK REF="REF-Hemil_x00e4_-2008" TYPE="REFERENCE">Hemilä 2008</LINK>). A further systematic review of 29 trials concluded that vitamin C reduces blood pressure (<LINK REF="REF-Juraschek-2012" TYPE="REFERENCE">Juraschek 2012</LINK>).</P>
<P>In randomised trials with critically ill intensive care unit (ICU) patients, vitamin C (<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK>) and the combination of vitamins C and E (<LINK REF="STD-Nathens-2002" TYPE="STUDY">Nathens 2002</LINK>) significantly decreased the length of mechanical ventilation and in a case-control study ICU patients administered vitamins C and E and selenium had shorter ICU stays and lower mortality rates (<LINK REF="REF-Collier-2008" TYPE="REFERENCE">Collier 2008</LINK>). Furthermore, dietary vitamin C intake modified the effect of vitamin E on the mortality of older male smokers and this modification was not explained by other substances in fruit and vegetables (<LINK REF="REF-Hemil_x00e4_-2009a" TYPE="REFERENCE">Hemilä 2009a</LINK>).</P>
<P>Although such findings indicate that the effects of vitamin C are not limited to preventing overt scurvy, their practical significance is not yet clear. Two large trials with US male physicians and female health professionals found no benefits of 0.5 G/day of vitamin C (<LINK REF="STD-Cook-2007" TYPE="STUDY">Cook 2007</LINK>; <LINK REF="STD-Sesso-2008" TYPE="STUDY">Sesso 2008</LINK>) and &#8805; 1 G/day of vitamin C had no effect on common cold incidence in the general population (<LINK REF="REF-Hemil_x00e4_-2013a" TYPE="REFERENCE">Hemilä 2013a</LINK>), but these findings are not discordant with the possibility that vitamin C administration might influence, for example, susceptibility to pneumonia or the severity of pneumonia in special conditions.</P>
<P>There is much evidence that vitamin C influences the immune system but its effects may be apparent only in particular conditions. For example, it is possible that variation in vitamin C intake does not influence the immune system in the ordinary Western population because of their relatively high dietary intake levels. Nevertheless, vitamin C might be a limiting factor in populations with low intakes. An extreme example is the high prevalence of frank vitamin C deficiency, apparent as scurvy, in refugee camps in the Horn of Africa: reported to have been up to 44% (<LINK REF="REF-WHO-1999b" TYPE="REFERENCE">WHO 1999b</LINK>).</P>
<P>In the early 1900s, Alfred Hess carried out extensive studies of scurvy and summarised a large series of autopsy findings: "pneumonia, lobular or lobar, is one of the most frequent complications [of scurvy] and causes of death" and "secondary pneumonias, usually broncho-pneumonic in type, are of common occurrence and in many [scurvy] epidemics constitute the prevailing cause of death" (<LINK REF="REF-Hess-1920" TYPE="REFERENCE">Hess 1920</LINK>). He further commented, in a major medical journal a decade later, that in "infantile scurvy . . . a lack of the antiscorbutic factor [vitamin C] which leads to scurvy, at the same time predisposes to infections [particularly of the respiratory tract] . . . Similar susceptibility to infections goes hand in hand with adult scurvy" (<LINK REF="REF-Hess-1932" TYPE="REFERENCE">Hess 1932</LINK>). In the early 1900s, Casimir Funk, who coined the term 'vitamin', pointed out that an epidemic of pneumonia in the Sudan disappeared when antiscorbutic (vitamin C-containing) treatment was given to the numerous cases of scurvy which appeared at about the same time (<LINK REF="REF-Robertson-1934" TYPE="REFERENCE">Robertson 1934</LINK>).</P>
<P>Vitamin C deficiency is not just of historical relevance. Cases of scurvy in hospitals have been described in several recent case reports, for example <LINK REF="REF-Holley-2011" TYPE="REFERENCE">Holley 2011</LINK> and <LINK REF="REF-Smith-2011" TYPE="REFERENCE">Smith 2011</LINK>, and one survey estimated that about 10% of hospitalised elderly patients had scurvy (<LINK REF="REF-Raynaud_x002d_Simon-2010" TYPE="REFERENCE">Raynaud-Simon 2010</LINK>). In the UK, 25% of men and 16% of women from low-income populations had vitamin C deficiency (&lt; 11 &#956;mol/L) (<LINK REF="REF-Mosd_x00f8_l-2008" TYPE="REFERENCE">Mosdøl 2008</LINK>) and in the USA 7% of healthy middle-class participants had vitamin C deficiency (<LINK REF="REF-Schleicher-2009" TYPE="REFERENCE">Schleicher 2009</LINK>). Thus, if pneumonia risk is increased by low intakes of vitamin C, this issue might also be important in parts of high-income countries.</P>
<P>Furthermore, vitamin C metabolism is affected by various infections, including pneumonia, as indicated by decreased levels in plasma, leucocytes and urine (<LINK REF="REF-Bakaev-2004" TYPE="REFERENCE">Bakaev 2004</LINK>; <LINK REF="REF-Bhoite-2011" TYPE="REFERENCE">Bhoite 2011</LINK>; <LINK REF="REF-Cemek-2006" TYPE="REFERENCE">Cemek 2006</LINK>; <LINK REF="REF-Chakrabarti-1955" TYPE="REFERENCE">Chakrabarti 1955</LINK>; <LINK REF="REF-Hemil_x00e4_-1997a" TYPE="REFERENCE">Hemilä 1997a</LINK>; <LINK REF="REF-Hemil_x00e4_-1999b" TYPE="REFERENCE">Hemilä 1999b</LINK>; <LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>; <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK>; <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK>). These changes in metabolism mean that vitamin C might have a treatment effect on pneumonia patients irrespective of their dietary intake. Since the 1930s, a few German and US physicians have proposed that vitamin C might be beneficial in the treatment of pneumonia (<LINK REF="REF-Bohnholtzer-1937" TYPE="REFERENCE">Bohnholtzer 1937</LINK>; <LINK REF="REF-Hochwald-1937" TYPE="REFERENCE">Hochwald 1937</LINK>). Gander and Niederberger concluded from a series of 15 cases that "the general condition is always favourably influenced [by vitamin C] to a noticeable extent, as is the convalescence, which proceeds better and more quickly than in cases of pneumonia which are not treated with vitamin C" (<LINK REF="REF-Gander-1936" TYPE="REFERENCE">Gander 1936</LINK>). Benefit from intravenous vitamin C was reported in a series of over 40 cases (<LINK REF="REF-Klenner-1948" TYPE="REFERENCE">Klenner 1948</LINK>; <LINK REF="REF-Klenner-1951" TYPE="REFERENCE">Klenner 1951</LINK>) and in three cases of viral pneumonia (<LINK REF="REF-Dalton-1962" TYPE="REFERENCE">Dalton 1962</LINK>). Large oral doses of vitamin C were also claimed to be beneficial in patients with viral pneumonia (<LINK REF="REF-Cathcart-1981" TYPE="REFERENCE">Cathcart 1981</LINK>; <LINK REF="REF-Luberoff-1978" TYPE="REFERENCE">Luberoff 1978</LINK>).</P>
<P>The effect of vitamin C on the common cold has been studied extensively. A major finding from the trials is the heterogeneity in its effects. Although the largest trials found no effect on common cold incidence, it was significantly reduced in trials with participants under heavy acute physical stress and in British males, the latter being explained as the result of a diet low in vitamin C when the studies were carried out (<LINK REF="REF-Hemil_x00e4_-1996" TYPE="REFERENCE">Hemilä 1996</LINK>; <LINK REF="REF-Hemil_x00e4_-1997b" TYPE="REFERENCE">Hemilä 1997b</LINK>; <LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>; <LINK REF="REF-Hemil_x00e4_-2013a" TYPE="REFERENCE">Hemilä 2013a</LINK>). Thus, the effects of vitamin C on other respiratory infections, such as pneumonia, might also be modified by various factors, such as physical stress and dietary vitamin C intake. Furthermore, two large trials found considerable divergence in the effects of vitamin C depending on the type of cold. Vitamin C decreased the incidence of 'chest colds' (-18%; cough or other chest symptoms) but not of 'simple colds' (+1%; runny nose or sneezing) (<LINK REF="REF-Elwood-1976" TYPE="REFERENCE">Elwood 1976</LINK>; <LINK REF="REF-Hemil_x00e4_-1997b" TYPE="REFERENCE">Hemilä 1997b</LINK>). Similarly, vitamin C decreased the incidence of 'throat colds' (-21%) but not 'nose colds' (-2%) (<LINK REF="REF-Anderson-1973" TYPE="REFERENCE">Anderson 1973</LINK>; <LINK REF="REF-Hemil_x00e4_-1997b" TYPE="REFERENCE">Hemilä 1997b</LINK>). These two trials thus suggest that vitamin C might have a greater effect on infections affecting the lower respiratory tract.</P>
<P>In close parallel with vitamin C, lipid-soluble vitamin E is interesting as these two antioxidants interact; vitamin C reduces oxidised vitamin E back to the reduced form (<LINK REF="REF-Hamilton-2000" TYPE="REFERENCE">Hamilton 2000</LINK>; <LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>; <LINK REF="REF-Hemil_x00e4_-2009a" TYPE="REFERENCE">Hemilä 2009a</LINK>; <LINK REF="REF-Packer-1979" TYPE="REFERENCE">Packer 1979</LINK>). In a large-scale trial the effect of vitamin E on the risk of pneumonia was significantly modified simultaneously by smoking and leisure-time physical activity, indicating heterogeneity in vitamin E effects between population groups (<LINK REF="REF-Hemil_x00e4_-2011a" TYPE="REFERENCE">Hemilä 2011a</LINK>). Even though direct extrapolation of findings from vitamin E studies to vitamin C are unjustified, the notion that various factors may modify the effects of antioxidants is fundamentally important in restricting broad generalisations from individual trials, irrespective of whether the finding is positive or negative and whether or not the trial is large and carefully conducted.</P>
<P>Approximately 10 mg/day of vitamin C prevents scurvy but the safe dose range extends to grams per day. In the US nutritional recommendations, the 'tolerable upper intake level' is stated to be 2 G/day for adults. However, the basis for this upper limit is the appearance of diarrhea (<LINK REF="REF-IOM-2000" TYPE="REFERENCE">IOM 2000</LINK>) which is a trivial adverse effect that disappears quickly with a reduction in intake. Furthermore, it has been stated that patients with pneumonia can take 100 G/day of vitamin C without developing diarrhea, possibly because of the changes in vitamin C metabolism (<LINK REF="REF-Cathcart-1981" TYPE="REFERENCE">Cathcart 1981</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2013-08-06 19:42:29 +1000" MODIFIED_BY="[Empty name]">
<P>Vitamin C is an antioxidant and its effects may be most pronounced under conditions when oxidative stress is increased. Viral and bacterial infections lead to the activation of leukocytes, which generate reactive oxygen and nitrogen species that oxidise extracellular vitamin C (<LINK REF="REF-Akaike-2001" TYPE="REFERENCE">Akaike 2001</LINK>; <LINK REF="REF-Galley-1996" TYPE="REFERENCE">Galley 1996</LINK>; <LINK REF="REF-Hemil_x00e4_-1984" TYPE="REFERENCE">Hemilä 1984</LINK>). This mechanism explains the decrease in vitamin C levels in pneumonia patients and in other patients with infections (see above). The oxidised form of vitamin C is imported to leukocytes where it is reduced back to vitamin C and its concentration can become very high (<LINK REF="REF-Nualart-2003" TYPE="REFERENCE">Nualart 2003</LINK>; <LINK REF="REF-Wang-1997" TYPE="REFERENCE">Wang 1997</LINK>). Exercise also causes oxidative stress because of increased oxygen consumption (<LINK REF="REF-Ashton-1999" TYPE="REFERENCE">Ashton 1999</LINK>; <LINK REF="REF-Powers-2008" TYPE="REFERENCE">Powers 2008</LINK>).</P>
<P>In the immune system, the major role of vitamin C seems to be as a physiological antioxidant, protecting host cells against oxidative stress caused by infections. In various experimental settings vitamin C has, for example, affected random migration and chemotaxis of phagocytes (<LINK REF="REF-Goetzl-1974" TYPE="REFERENCE">Goetzl 1974</LINK>), the transformation of influenza virus-infected lymphocytes (<LINK REF="REF-Manzella-1979" TYPE="REFERENCE">Manzella 1979</LINK>), the production of interferon (<LINK REF="REF-Siegel-1975" TYPE="REFERENCE">Siegel 1975</LINK>), the replication of viruses (<LINK REF="REF-Bissell-1980" TYPE="REFERENCE">Bissell 1980</LINK>) and gene expression of monocyte adhesion molecules (<LINK REF="REF-Rayment-2003" TYPE="REFERENCE">Rayment 2003</LINK>); see reviews in: <LINK REF="REF-Beisel-1982" TYPE="REFERENCE">Beisel 1982</LINK>, <LINK REF="REF-Hemil_x00e4_-1997a" TYPE="REFERENCE">Hemilä 1997a</LINK>, <LINK REF="REF-Thomas-1978" TYPE="REFERENCE">Thomas 1978</LINK> and <LINK REF="REF-Webb-2007" TYPE="REFERENCE">Webb 2007</LINK>.</P>
<P>In dozens of animal studies, vitamin C increased resistance against diverse viral and bacterial infections and against purified bacterial toxins (<LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>). In a laboratory study, vitamin C deficiency increased the incidence of pneumonia in rhesus monkeys (<LINK REF="REF-Sabin-1939" TYPE="REFERENCE">Sabin 1939</LINK>). In mice, influenza infection decreased vitamin C concentration in bronchoalveolar lavage fluid (<LINK REF="REF-Buffinton-1992" TYPE="REFERENCE">Buffinton 1992</LINK>) and, also in mice, vitamin C deficiency increased lung pathology caused by influenza infection (<LINK REF="REF-Li-2006" TYPE="REFERENCE">Li 2006</LINK>).</P>
<P>See the <LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK> for further considerations on the possible mechanisms of vitamin C effect on pneumonia.</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Pneumonia is a fairly common and severe infection and vitamin C is a safe and inexpensive essential nutrient. The possibility that vitamin C might affect susceptibility to pneumonia, even in restricted population groups, is worthy of examination. Similarly, the possibility that vitamin C treatment might affect the duration or severity of pneumonia, or both, is worthy of systematic consideration. One previous meta-analysis assessed the preventive effects of vitamin C on pneumonia (<LINK REF="REF-Hemil_x00e4_-1997c" TYPE="REFERENCE">Hemilä 1997c</LINK>) but the therapeutic effect on pneumonia was not assessed systematically before this review.</P>
<P>Links to the publications cited in this section, for which full-text versions are available, can be found at <A HREF="http://www.mv.helsinki.fi/home/hemila/CP">http://www.mv.helsinki.fi/home/hemila/CP</A>.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-06-27 13:34:50 +1000" MODIFIED_BY="[Empty name]">
<P>To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-08-07 19:40:43 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-08-07 19:40:02 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2011-03-25 20:44:32 +1000" MODIFIED_BY="Harri Hemilä">
<P>For preventive trials of vitamin C supplementation we used controlled trials. The use of placebo was not required as it seems unlikely that being aware or not of taking vitamin C would affect the occurrence of a severe infection. Also, since a recent meta-analysis of trials comparing a placebo group with a no treatment group found no evidence of a placebo effect on binary outcomes (<LINK REF="REF-Hrobjartsson-2001" TYPE="REFERENCE">Hrobjartsson 2001</LINK>; <LINK REF="REF-Hrobjartsson-2010" TYPE="REFERENCE">Hrobjartsson 2010</LINK>), there is no empirical evidence indicating that the placebo effect might affect the occurrence of pneumonia.</P>
<P>For treatment trials of vitamin C on the severity and duration of pneumonia we used placebo-controlled trials since the outcome (for example, severity) may be affected by the awareness of the treatment by the patients. Also, the recent meta-analysis of trials comparing a placebo group with a no treatment group found evidence of a placebo effect in trials focusing on pain (<LINK REF="REF-Hrobjartsson-2001" TYPE="REFERENCE">Hrobjartsson 2001</LINK>; <LINK REF="REF-Hrobjartsson-2010" TYPE="REFERENCE">Hrobjartsson 2010</LINK>). A placebo control may, therefore, be crucial for the validity of treatment observations.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-08-05 02:03:07 +1000" MODIFIED_BY="Liz Dooley">
<P>For prevention trials there was no age restriction in the participants.</P>
<P>For treatment trials we restricted trials to participants with pneumonia (both community-acquired and hospital-acquired (nosocomial) pneumonia) with no age restrictions.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Administration of vitamin C (ascorbic acid or its salts) to one trial group, either orally or intravenously. There were no restrictions on the dosage and frequency of administration of vitamin C and treatment trials with a single dose were also considered. We excluded trials in which vitamin C was administered along with other substances, such as other vitamins. We included studies in which vitamin C had a co-intervention if the control group only had the co-intervention so that the only difference was vitamin C administration.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-08-07 19:40:02 +1000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-08-07 19:40:02 +1000" MODIFIED_BY="[Empty name]">
<P>Community-acquired pneumonia and hospital-acquired (nosocomial) pneumonia are very different types of medical conditions and we analysed them separately.</P>
<SUBSECTION>
<HEADING LEVEL="5">Community-acquired pneumonia</HEADING>
<P>The preventive effect of vitamin C:</P>
<OL>
<LI>incidence of pneumonia during vitamin C supplementation.</LI>
</OL>
<P>The treatment effect of vitamin C:</P>
<OL>
<LI>duration and severity of pneumonic episodes;</LI>
<LI>death caused by pneumonia.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Hospital-acquired (nosocomial) pneumonia</HEADING>
<P>The preventive effect of vitamin C:</P>
<OL>
<LI>incidence of pneumonia during vitamin C supplementation.</LI>
</OL>
<P>The treatment effect of vitamin C:</P>
<OL>
<LI>duration and severity of pneumonic episodes;</LI>
<LI>death caused by pneumonia.</LI>
</OL>
<P>For our review pneumonia was defined operationally as the disease that the original trial authors classified as pneumonia. The basis of the diagnosis by the original authors is described in the <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK> section. We did not require that the pneumonia diagnosis was based on chest X-radiography (CXR) but we also accepted a clinical diagnosis of pneumonia (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for detailed comments on this issue).</P>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-07-15 11:36:16 +1000" MODIFIED_BY="Liz Dooley">
<OL>
<LI>Laboratory findings, such as C-reactive protein or erythrocyte sedimentation rate.</LI>
<LI>CXR changes and body temperature changes during treatment.</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-08-06 19:46:01 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-08-06 19:46:01 +1000" MODIFIED_BY="[Empty name]">
<P>For this 2013 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 3, part of <I>The Cochrane Library</I>, www.thecochranelibrary.com (accessed 8 April 2013) which contains the Acute Respiratory Infections Group's Specialised Register, MEDLINE (1950 to March week 4, 2013), EMBASE (1974 to April 2013) and Web of Science (1945 to April 2013). Details of the original search are shown in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>We searched CENTRAL and MEDLINE using the following search strategy. We did not use a filter to identify randomised trials as there were few results. We adapted the search for EMBASE (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>) and Web of Science (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>).</P>
<P>1 exp Pneumonia/<BR/>2 pneumon*.tw.<BR/>3 bronchopneumon*.tw.<BR/>4 exp Bronchitis/<BR/>5 bronchit*.tw.<BR/>6 or/1-5<BR/>7 exp Ascorbic Acid/<BR/>8 l-ascorb*.tw,nm.<BR/>9 ascorb*.tw,nm.<BR/>10 vitamin c.tw,nm.<BR/>11 vit c.tw,nm.<BR/>12 or/7-11<BR/>13 6 and 12</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-04-12 16:18:02 +1000" MODIFIED_BY="Liz Dooley">
<P>Previously, <LINK REF="REF-Briggs-1984" TYPE="REFERENCE">Briggs 1984</LINK> carried out extensive searches of the literature and published a bibliography containing 413 references to papers related to vitamin C and infections. We perused the Briggs bibliography and other pertinent reviews and publications along with the results of the database searches. There were no language restrictions in the literature searches.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-08-07 19:40:43 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2011-03-16 14:16:45 +1000" MODIFIED_BY="Liz Dooley">
<P>The contact author (HH) searched the literature and both review authors (HH, PL) independently assessed the extracted titles and abstracts to identify potentially relevant articles. We excluded trials failing to meet the inclusion criteria. When we disagreed on the relevance of an article, we discussed it until we reached a consensus.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-06-06 17:52:08 +1000" MODIFIED_BY="Liz Dooley">
<P>Both review authors (HH, PL) independently extracted relevant data from the articles selected. When we differed in the interpretation of study findings we sought a consensus. In their report, <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> published the respiratory symptom scores for all participants and for the most severely ill patients; for this review we calculated the scores for the less ill patients.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-06-04 20:23:05 +1000" MODIFIED_BY="[Empty name]">
<P>We recorded the following quality features of the trials: allocation concealment, blinding, proportion of drop-outs and other relevant features that may limit the validity of the trial. We did not calculate any quality scores for the selected trials since "quality scores are at best useless and at worst misleading" (<LINK REF="REF-Greenland-1994" TYPE="REFERENCE">Greenland 1994</LINK>). We agree with the <LINK REF="REF-Shapiro-1997" TYPE="REFERENCE">Shapiro 1997</LINK> comment that quality is best evaluated qualitatively. The<I> Cochrane Handbook for Systematic Reviews of Interventions</I> also states that "The use of scales for assessing quality or risk of bias is explicitly discouraged in Cochrane reviews" (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-06-10 05:17:48 +1000" MODIFIED_BY="[Empty name]">
<P>We planned to calculate risk ratios (RR) for dichotomous outcome variables. However, in the identified prophylactic trials the number of pneumonia cases in the vitamin C groups was very low (zero to two cases) and, therefore, we decided to use the Peto method for calculating the odds ratio (OR), which does not need corrections for zero cell counts (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>Also, with only a few cases observed in the prophylactic trial groups, the mid-P value is the most appropriate method to calculate the P values for the differences in the treatment groups (<LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>; <LINK REF="REF-Lydersen-2009" TYPE="REFERENCE">Lydersen 2009</LINK>) and was used when comparing groups with small numbers of cases. We used two-tailed P values in this review.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-08-07 19:40:15 +1000" MODIFIED_BY="[Empty name]">
<P>The <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> study reported the number of pneumonia cases per seven administrative groups of the school. Thus, the unit of analysis is the group of schoolchildren in the administrative division. Glazebrook states that "The youths of one division worked as a unit, and occupied certain tables in the dining hall. To some extent each division occupied particular dormitories but this separation was not absolute and there was a fair amount of mixing of divisions in the sleeping quarters. Sleeping and feeding conditions were, of course, the same for all divisions. Careful records had been kept of the incidence of all infections for 1½ years before the observations described here were begun. In the preceding year there had been an epidemic of tonsillitis, which had affected all the divisions uniformly, so that they could not be regarded as separate units within the larger population." Therefore, we consider that the schoolboys had a similar risk of pneumonia in each division and we carried out our primary analysis by the vitamin C and the no vitamin C groups. However, as a sensitivity analysis, we also analysed the data by administrative units (see <LINK TAG="RESULTS" TYPE="SECTION">Results</LINK>).</P>
<P>Other studies included in our analyses do not have unit of analysis concerns.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2011-03-31 20:17:00 +1000" MODIFIED_BY="Harri Hemilä">
<P>None of the trials had missing data that we needed to impute.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed the heterogeneity of comparisons by using the I<SUP>2 </SUP>statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). This examines the percentage of total variation across studies that is due to heterogeneity rather than chance. A value of the I<SUP>2</SUP> statistic greater than about 70% indicates a high level of heterogeneity. We also used the Chi<SUP>2 </SUP>test to calculate the probability that the observed heterogeneity was caused by chance.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-07-12 19:27:11 +1000" MODIFIED_BY="Liz Dooley">
<P>We did not construct funnel plots as we do not consider them to be useful when considering whether there is publication bias or not (<LINK REF="REF-Ioannidis-2007" TYPE="REFERENCE">Ioannidis 2007</LINK>; <LINK REF="REF-Lau-2006" TYPE="REFERENCE">Lau 2006</LINK>; <LINK REF="REF-Sterne-2011" TYPE="REFERENCE">Sterne 2011</LINK>).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-04-12 16:18:54 +1000" MODIFIED_BY="Liz Dooley">
<P>We planned that if a number of trials were available with sufficient uniformity in settings and outcome definitions, we would pool the data; but, if the trials were heterogeneous, either statistically or clinically, we would present them separately. There is no statistical heterogeneity in <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK> but the studies are clinically so divergent that pooling was inappropriate.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-08-07 19:40:26 +1000" MODIFIED_BY="[Empty name]">
<P>We included both community-acquired and hospital-acquired (nosocomial) pneumonia in this review. Due to their substantial clinical differences, we analysed them separately.</P>
<P>We did not require that pneumonia definition was based on CXR (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) but we planned to carry out subgroup analyses based on the rigour of outcome definition (CXR or not) and on the level of blinding of outcome assessments. Given the trials we identified, this did not differ from the sensitivity analysis based on the methodological quality of the trials.</P>
<P>We did not set limits on the vitamin C doses for the inclusion of trials but we planned to carry out subgroup analyses based on dosage. In the preventive trials, we set the limit of subgroup analysis to 100 mg/day, since it is close to the dosage leading to maximum vitamin C plasma levels in healthy people. In the treatment trials, we set the limit of subgroup analysis to 1000 mg/day, since there is evidence of changes in vitamin C metabolism in infections and larger doses might be needed for significant therapeutic effects. We did not find suitable variation in the doses for a between-study subgroup analysis but there was within-study variation in the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> trial (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-08-07 19:40:43 +1000" MODIFIED_BY="[Empty name]">
<P>Two of the identified trials were double-blind, placebo-controlled, randomised controlled trials (RCTs) (<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK>; <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK>) whereas three studies were methodologically less satisfactory (<LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK>; <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK>; <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK>). We carried out sensitivity analysis by excluding the latter three methodologically poorer quality trials.</P>
<P>
<LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> had a unit of observation of an administrative group in a boarding school. In the primary analysis, we assumed a similar risk for each participant in each administrative unit but as a sensitivity analysis we also analysed their data by the administrative groups.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-08-07 19:41:01 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-08-07 19:33:48 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>We identified no new trials for inclusion in the 2013 update searches (out of 125 records recovered). The MEDLINE search for the 2013 update retrieved 12 publications, the EMBASE search retrieved 119, the Web of Science search 21 and the CENTRAL search 0 publications. From these search results we found no new trials in addition to the earlier identified three controlled trials which provided data pertinent to the prevention of pneumonia with vitamin C supplementation and two trials which provided data on the therapeutic effect of vitamin C. For earlier searches, see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>. However, in the 2013 update we identified an earlier study which had been missed since 'pneumonia' was not listed in its key words (<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK>).</P>
<P>The main features of the included trials are summarised in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. The methods are described here in more detail, largely using direct excerpts from the original papers as these show the strengths and weaknesses of the trials in the words of the original trial authors. <B>
<BR/>
</B>
</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-08-07 19:33:48 +1000" MODIFIED_BY="[Empty name]">
<P>Only six trials were identified. Their main features are briefly summarised in the table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> but described in detail in this section because their weaknesses and strengths are crucial when considering the validity of their findings and the possibility of extrapolating their findings.</P>
<SUBSECTION>
<HEADING LEVEL="4">Tanaka 2000</HEADING>
<P>
<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> was primarily interested in resuscitation fluid volume requirements and oedema generation in severely burnt patients. The study is reported as a "randomised study" but the methods section states that "randomisation was performed according to the month of admission" suggesting that randomisation may have been used as a synonym for allocation. There is no description of the level of blinding. Incidence of pneumonia is reported as a secondary outcome but the criteria for diagnosis are not described.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Hunt 1994</HEADING>
<P>
<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> stated that "The patients enrolled into this . . . study were suffering from acute bronchitis (often acute exacerbation of chronic bronchitis) or bronchopneumonia. Patients suspected or known to be suffering from lung cancer were excluded from the study, as were those who were judged by the clinician to be at high risk of death within a day or two of admission" (page 213). Thus the patients in this study were a mixture of bronchitis and pneumonia patients, whereas in our methods section our purpose was to focus on pneumonia. However, with the soft clinical definition of pneumonia, as mentioned in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> and <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK> sections and the high false negative proportion in CXR versus high-resolution computed tomography (HRCT) comparison (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), we included this trial in our analysis. Nevertheless, the wider definition of lower respiratory tract infection in this trial needs to be considered when drawing conclusions. "The patients were enrolled over a period of three years and were admitted mainly in the winter months. . . acute respiratory infection had, in all cases, been the primary reason for hospitalisation" (page 213). "For consistency all clinical assessments were performed by the same Associate Specialist. Three main diagnostic features of infective respiratory conditions, namely cough, breathlessness and radiographic evidence of chest infection were used. Each was scored by the clinician according to severity. . . Then for each person, at each assessment interval, his or her three main diagnostic feature scores were added to give the 'total respiratory score'. By this procedure, the worst score that could be achieved by the most severely ill patient (whilst still alive) was 9, whilst those who were completely well with regard to the respiratory condition would score 3. A score of 10 was given for subjects who died during the trial. . . Assessments were made on admission (0 weeks) and at 2 and 4 weeks after admission. If patients were discharged from hospital as 'well' before 4 weeks, therapy was discontinued and they were assumed to remain well for up to 4 weeks, for the purpose of clinical scoring (none of the patients discharged were readmitted during their 4 week assessment period)" (page 213). "The clinical score results were approximately normally distributed..." (page 214), which allowed us to use the t-test in the comparison of the clinical score values. "After the initial clinical assessment . . . the patients commenced placebo or vitamin C therapy to which they were allocated on a randomised 'double-blind' basis. This was in addition to their normal medication" (page 213). Thus, the test of vitamin C effects was "over and above those of normal medication (mainly antibiotics and cough medicines) to which all participants were exposed" (page 217). "The vitamin C and placebo tablets were indistinguishable from each other by look or taste" (page 213). "None of the subjects who died on the trial had any secondary diagnosis, including ischaemic heart disease, and death was attributed directly to respiratory infection in each case" (page 217). At baseline, the mean plasma vitamin C level was 23.3 &#956;mol/L and 35% of patients had a vitamin C level lower than 11.4 µmol/L (page 215). After four weeks, the vitamin C level was 94.9 &#956;mol/L (+307%) in the vitamin C group but only 24.4 &#956;mol/L (+5%) in the placebo group (page 215).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pitt 1979</HEADING>
<P>The authors of <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> were primarily interested in the effect of vitamin C on the incidence of the common cold. However, other severe respiratory infections including pneumonia were also recorded. "The participants were male marine recruits who underwent 11 weeks of recruit training at Parris Island, South Carolina in October to December. . . Pill taking did not begin until the recruit's third week at Parris Island" (page 908). "These 862 recruits were assigned randomly to either the vitamin C or placebo group from a list of consecutive numbers randomised in pairs. Randomisation was carried out by individual recruits within each platoon" (page 908). "Of the 862 recruits who began taking the pills, 64 recruits (34, vitamin C; 30, placebo) were removed from their platoons by the US Marine Corps for further training or for discharge during the eight-week study period. An additional 123 recruits (64: vitamin C; 59: placebo) were excluded from the final analysis because they did not continue to take their pills for the eight-week study period. One additional recruit was eliminated from the vitamin C group because of recurrent urticaria related to taking the tablets" (page 909). "Before the initiation of pill taking, each recruit received adenovirus 4 and influenza vaccines and either intramuscular penicillin G benzathine or oral erythromycin estolate as streptococcal prophylaxis" (page 908). "Pill taking was supervised and observed by the drill instructors in each platoon. Neither the recruits or drill instructors nor the physicians and corpsmen who treated the recruits were aware of which pill any individual was taking" . . . "The placebo tablets were formulated from citric acid and were indistinguishable in appearance and taste from the vitamin C tablets" (page 908). "Pneumonia developed in eight recruits. . . Each of these eight recruits had typical roentgenographic and physical signs of pneumonia, although five recruits were febrile and only four recruits had elevated white blood cell counts. Pneumococci were isolated from the sputum in three recruits and seen intracellularly on Gram's stain in two other recruits. Two of these recruits also had four-fold increases in parainfluenza titers . . . Each of these recruits returned to his platoon after a mean Medical Dispensary stay of 4.4 days" (page 910). Pitt and Costrini did not estimate dietary vitamin C intake; however, their participants' mean vitamin C plasma level was rather high initially, 56 &#956;mol/L (10 mg/L) (page 909), which would correspond to a dietary intake of 100 mg/day or more (<LINK REF="REF-Levine-1996" TYPE="REFERENCE">Levine 1996</LINK>). After six weeks, the vitamin C level was 77 &#956;mol/L (+36%) in the vitamin C supplemented group and 52 &#956;mol/L (-7%) in the placebo group (page 909).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mochalkin 1970</HEADING>
<P>The paper by <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> is in Russian and a translation into English is available. The selection criteria for the participants were not described; neither were many other methodologically relevant aspects. This is a three-arm trial with one control arm and two vitamin C arms with different doses. Placebo was not mentioned and probably was not used in the control arm. However, participants in two other trial arms were administered different doses of vitamin C and the lower-dose arm was used as the reference group in the primary analysis of this review because it seems unlikely that the difference between these arms might be explained by the placebo effect. "The group of patients comprised 140 males diagnosed with acute pneumonia hospitalised during the first two days of onset of the disease [124 patients were 20 to 60 years of age, and 16 were over 60 years]. Depending on the mode of basic treatment, the patients were divided into three groups: Group I (70 patients) was treated with antibiotics without ascorbic acid (25 patients were treated with penicillin, 15 with streptomycin, 15 with penicillin and streptomycin, and 15 with tetracycline); Group II (39 patients) was treated with antibiotics combined with vitamin C (50 mg per 100,000 antibiotic units) (15, 8, 8, 8 patients in the antibiotic groups, respectively); Group III (31 patients) was treated with antibiotics combined with ascorbic acid (100 mg per 100,000 antibiotic units) (10, 7, 7, 7 patients in the antibiotic groups, respectively)" (page 18). Ascorbic acid powder was taken orally. Both antibiotics and ascorbic acid were used for 10 days . . . All patients were tested under equal conditions of placement, care, and nutrition, and were subjected to a complex therapy which included antibiotics . . . To monitor the effectiveness of the employed methods of treatment, we used the following parameters: dynamics of temperature normalisation, erythrocyte sedimentation rate, leucocyte quantity in the peripheral blood, timing of wet rattle disappearance, duration of roentgenologically-determined changes in the lungs, and the mean period of recovery" (page 18). At baseline, the mean plasma vitamin C level was 41 &#956;mol/L. After 10 days treatment, the vitamin C level was 43 &#956;mol/L (+7%) in the higher-dose vitamin C group and 35 &#956;mol/L (-15%) in the low-dose vitamin C group but only 23 &#956;mol/L (-44%) in the control group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Kimbarowski 1967</HEADING>
<P>The <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> trial was poorly described. Although published in German, an English translation is available. The main focus of the trial was to examine a chemical test, which is not relevant to the current review. However, as a secondary issue, in their report the authors reported the number of bronchopneumonia cases in vitamin C and control groups after hospitalisation. The trial authors excluded the pneumonia cases from their further study (page 2414). For this review the pneumonia cases are relevant since they occurred after vitamin C supplementation was initiated. Although the pneumonia cases occurred after hospitalisation, they occurred within a week and thus did not fall into the category of nosocomial pneumonia. "The studies were conducted with the use of soldiers almost all of whom were of the same age and received the same diet . . . The diagnosis of influenza was based mainly on the clinical pictures and epidemiological data with serological confirmation in a series of cases involving the type A virus." The geographic location where the trial was carried out, the military institution(s), the hospital in which the trial was carried out and the characteristics of the soldiers were not described. The allocation method was not described but the study arms were of closely similar size (112 versus 114 in the control and vitamin C arms, respectively, before excluding the bronchopneumonia cases) so it is probable that allocation occurred sequentially to the two trial arms. The two arms were well-balanced for severity of the influenza. The number of severe cases was 64 versus 65, moderate cases 26 versus 32 and mild cases 12 versus 14 in the two arms respectively (page 2414); the pneumonia cases were not included in these figures. A placebo was not mentioned in the paper and apparently was not used. Blinding of outcome assessment was not described. However, since pneumonia was a secondary issue in the study, the trial authors did not have reason to compare the number of pneumonia cases between the trial arms. It seems improbable, therefore, that the trial authors had substantial bias in their diagnosis of pneumonia. CXR ("Röntgenoscopie") was explicitly mentioned in the paper as a method that was used. It is probable that the diagnosis of bronchopneumonia was based on the CXR but this was not explicitly stated in the paper.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Glazebrook 1942</HEADING>
<P>The <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> trial was the oldest trial identified. The structure of the paper is quite different from more modern trial reports: "In a large training school under our observation there were some 1500 youths aged 15-20 years. For the most part they were drawn from the lower wage-earning classes . . . The food distribution [at the school] was badly managed. . . Often 8 hr. elapsed between the time the food was cooked and its arrival on the dining tables . . .The total intake of vitamin C varied from about 10 to 15 mg per student per day" (pages 4 to 5). "Pure ascorbic acid powder was added to . . . the morning cocoa, and an evening glass of milk. The mixing was done in bulk in the kitchens before issue. The powder dissolved quickly and easily, and did not alter the appearance or taste of the vehicle" (page 7). We consider that the trial corresponds functionally to a placebo-controlled trial because the participants were unable to identify the treatment, although no inactive powder was added to the food of the control group. "The establishment was divided into seven groups or divisions for administrative purposes. The youths of one division worked as a unit, and occupied certain tables in the dining hall. To some extent each division occupied particular dormitories but this separation was not absolute, and there was a fair amount of mixing of divisions in the sleeping quarters. Sleeping and feeding conditions were, of course, the same for all divisions. Careful records had been kept of the incidence of all infections for 1½ years before the observations described here were begun. In the preceding year there had been an epidemic of tonsillitis, which had affected all the divisions uniformly, so that they could not be regarded as separate units within the larger populations" (page 12). "The observations were made by supplying vitamin C in the form of pure ascorbic acid to one or more divisions. This was considered to be the only practical method of carrying out the observations without introducing unnecessary complications. For example, it was not possible to choose boys at random as it would have been impossible to supply them with vitamin C-treated cocoa or milk in the dining room. With the method actually chosen, all that was necessary was to add vitamin C to the supplies of cocoa or milk serving the tables for the appropriate divisions" (page 12). "Moreover, all of the divisions had a population more or less the same as regards duration of stay in the establishment ('institution age'). Infectious diseases were more common amongst those who had more recently joined the institution" (page 12). "When a youth felt ill he was admitted to Sick Quarters unless his complaint was very mild. . . The admission to and discharge from the hospital was not under our control " (pages 13 to 14). [As to pneumonia:] "These cases were subjected to special investigations by us (X-rays, etc.) to establish certain criteria for the diagnosis" (page 16). However, it was not stated whether the diagnosis of pneumonia was carried out by the trial authors of the paper or the physicians at the Sick Quarters. Although the method of diagnosing pneumonia was not described in detail in the paper, with the given descriptions and the severe pathological processes occurring in pneumonia it seems unlikely that vitamin C treatment would have substantially affected the diagnosis of pneumonia.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Eleven excluded studies are described in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table. Links to the trial reports and translations can be found at <A HREF="http://www.mv.helsinki.fi/home/hemila/CP">http://www.mv.helsinki.fi/home/hemila/CP</A>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-08-07 19:33:51 +1000" MODIFIED_BY="[Empty name]">
<P>Two of the trials were double-blinded, placebo-controlled RCTs without serious methodological defects and, from the descriptions, there was appropriate allocation concealment in these trials (<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK>; <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK>). Four other trials had methodological shortcomings of varying degrees, as described in the previous section (<LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK>; <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK>; <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK>; <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK>) and the possible role of these shortcomings in the interpretation of the study results is considered in the <LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK> section.</P>
<P>The risk of bias is summarised in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<ALLOCATION MODIFIED="2013-08-07 19:33:51 +1000" MODIFIED_BY="Liz Dooley">
<P>
<LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> describes that marine recruits were assigned randomly to the groups from a list of consecutive numbers randomised in pairs. Randomisation was carried out by individual recruits within each platoon. Since the study was double-blind, allocation was concealed. <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> states that patients commenced placebo or vitamin C therapy to which they were allocated on a randomised, double-blind basis, without giving further details. Since the study was double-blind, allocation was concealed. <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> allocated schoolboys as administrative units of the boarding school. Thus, allocation was not concealed for the researchers but it may have been concealed for the schoolboys since the researchers pointed out that vitamin C was added in the kitchen and it did not alter the appearance or taste of the vehicle (cocoa or milk). The number of participants in the vitamin C and placebo arms of the <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> was closely equal suggesting alternative allocation but this is not explicitly stated. The report does not give any basis to assume allocation concealment by the researchers, while no conclusions can be drawn for the participants. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> has groups of quite different sizes indicating that it was not randomised. No description is given about the forming of the study groups. <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> does not describe the method of allocation; although they use the term "randomised" it is possible that the groups were formed by the treatment month: "randomisation was performed according to the month of admission" (p.327).</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>The <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> and <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> studies were double-blind. <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> stated that vitamin C was added in the kitchen and it did not alter the appearance or taste of the vehicle (cocoa or milk), indicating that the participants were blinded for vitamin C administration (see <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK>). Glazebrook's description further indicates that the diagnosis of pneumonia was made in the Sick Quarter by physicians who were not involved in the study so that they probably were blinded as to the treatment group (see <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK>). The level of blinding cannot be concluded for the <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK>, <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> and the <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> trials.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-08-06 19:54:00 +1000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> stated that 64 marine recruits (7.4% of the initial 862) were removed from their platoons and did not continue in the trial but there was no difference between the study arms. An additional 123 recruits (14.3% of the initial 862) were excluded from the analysis because they did take their pills but there was no difference between the study arms. One recruit was removed from the vitamin C group because of adverse effect. Thus, 22% of participants were not included in analysis but there was no difference between the study arms. <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> states that four patients were excluded because of "incomplete information" without further details and 57 remained for the analysis; the distribution of the excluded patients is not described. The <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> study was carried out in a boarding school and the report does not indicate that school children might have dropped out from the trial. <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> did not describe any drop-outs before pneumonia was diagnosed. The <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> study was carried out in a hospital in the former Soviet Union. No comment on drop-outs is given in the report. However, the distribution of the usage of four different antibiotic treatments is given in the three arms and these groups are identical in size within the arms which suggests that they were planned and that there were no drop-outs. In the <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> trial, there is no indication of drop-outs.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-07-15 11:54:01 +1000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK>, <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK>, <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> and <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> considered pneumonia either of secondary interest or as a nuisance and therefore the findings for pneumonia were not selectively reported because of the type of findings. <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> was specifically interested in the treatment of pneumonia but there are no indications in the paper that the reported outcomes would have been selected from a larger set of outcomes. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> measured temperature, erythrocyte sedimentation rate, leukocyte level, time of wet rattle disappearance, time of normalisation of CXR and the mean period of recovery. All these outcomes were reported.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2011-03-31 20:24:25 +1000" MODIFIED_BY="Harri Hemilä">
<P>See the section <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK> above.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-08-07 19:41:01 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Preventing community-acquired pneumonia</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Incidence of pneumonia</HEADING>
<P>Three trials reported the number of pneumonia cases in the vitamin C and control groups. All these trials found an 80% or greater decrease in the incidence of pneumonia in the vitamin C group (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). Since the number of cases in the vitamin C groups was very low (zero to two cases in all of the trials) we used the Peto method for calculating the odds ratio (OR) as an approximation to the risk ratio (RR).</P>
<P>The confidence intervals (CI) in the three trials were wide and overlapped substantially and there is no evidence of statistical heterogeneity (Chi<SUP>2 </SUP>(2 df) = 0.03 and I<SUP>2</SUP> statistic = 0%). However, the trials were clinically so heterogeneous that we did not calculate a pooled estimate of effect because we did not consider that such a pooled estimate was meaningful. Nevertheless, all three trials tested the general question of whether vitamin C differs from placebo regarding susceptibility to pneumonia.</P>
<P>We used the Peto OR method to calculate an estimate of OR and its 95% CI in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>. However, with only a few observed cases, the exact 95% CI is more appropriate than the approximate 95% CI levels: for <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK>, exact OR = 0.0 (95% CI 0.0 to 0.80; mid-P = 0.012), for <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK>, OR = 0.18 (95% CI 0.02 to 0.82; mid-P = 0.018) and for <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK>, OR = 0.15 (95% CI 0.0 to 1.04; mid-P = 0.044). The combined mid-P value (2-t) for the three trials was 0.00004 (<LINK REF="REF-Hemil_x00e4_-1997c" TYPE="REFERENCE">Hemilä 1997c</LINK>), indicating that the differences between the vitamin C and control arms in these three trials were unlikely to be explained by random variation.</P>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup and sensitivity analyses</HEADING>
<P>We carried out sensitivity analysis in this set of prophylactic trials by excluding trials that did not use randomisation and placebo. This left <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> as the only trial with high methodological quality. Nevertheless, the findings of the <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trial did not differ from the other two trials. As noted above, the trials were clinically heterogeneous and we do not expect the same treatment effect in such variable conditions. However, there was no evident trend for the most positive findings to occur in methodologically less satisfactory trials.</P>
<P>Subgroup analysis by vitamin C dosage of less or more than 100 mg/day did not reveal any effect of the dose. However, the trials were clinically so heterogeneous and the number of cases so low that we could not make any conclusions about dose-dependency. All three trials mentioned the usage of the chest radiograph (CXR) but none of them provided a well-defined case definition of pneumonia. Thus we did not carry out a subgroup analysis by use of a CXR for diagnosis.</P>
<P>In the <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> trial, allocation to treatment groups was carried out by institute 'divisions' and not on the basis of individual boys. Therefore, we also analysed the <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> trial using the 'division' as the unit of observation. Distribution of pneumonia cases in the five control divisions was 5, 3, 2, 4 and 3 (mean 3.4 cases per division) and in the two vitamin C divisions it was 0 and 0. We assumed that the mean of the control divisions was a suitable estimate for the Poisson distribution mean and used that assumption as a basis for statistical analysis. The size of the individual divisions was not stated in the paper but the two vitamin C divisions had on average 167 boys (335/2) and the five control divisions 220 boys (1100/5), thus the size of the vitamin C divisions was 0.76 times the size of the control divisions. We adjusted the mean incidence by this ratio, so that we expected 2.6 pneumonia cases per vitamin C division, assuming the same incidence as for the control divisions. With this Poisson mean, we calculated the probability that there was no case of pneumonia in two separate vitamin C divisions as having a P value of 0.006. Accordingly, using a 'division' as the unit of observation does not change the conclusions.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Treating community-acquired pneumonia</HEADING>
<P>Two trials examined the effect of vitamin C on patients with pneumonia (<LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK>), or pneumonia and bronchitis (<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Duration and severity of pneumonic episodes</HEADING>
<P>As a measure of pneumonia severity, <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> used 'total respiratory score', which had a range from three (least ill) to nine (most ill) and 10 (dead). On this pneumonia severity score, vitamin C caused a marginally significant benefit at four weeks: P = 0.053, which is based on a decrease in the respiratory score: -2.31 (standard deviation (SD) 2.44) versus -3.43 (SD 1.77) in the placebo and vitamin C groups, respectively. However, the benefit was restricted to patients who were most severely ill when admitted to the hospital (see subgroup analysis below; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<P>
<LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> had three trial arms: control, low vitamin C and high vitamin C. The control arm was not administered a placebo. Therefore, we restricted our main analysis to the comparison of the two vitamin C arms so that the low vitamin C group served as the placebo group in the comparison (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). Because of Mochalkin's protocol, the mean vitamin C dose of the higher-dose arm was double that of the lower-dose arm, although the dosage ranges within both vitamin C arms overlapped (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). There was a statistically highly significant decrease in the duration of pneumonia in the high vitamin C dose arm compared with the low dose arm (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; P &lt; 0.0001).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Death caused by pneumonia</HEADING>
<P>
<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> found an 85% lower mortality in the vitamin C group compared with the placebo group but this comparison was based on six cases only (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; mid-P = 0.12). All deaths occurred in the patients who were most severely ill when admitted to the hospital and all deaths were caused by the respiratory infection.</P>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup and sensitivity analyses</HEADING>
<P>
<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> published the total respiratory score values for all participants and for the most severely ill participants (baseline score eight or nine). We calculated the mean scores in the less ill patients (baseline score seven or less). There is significant heterogeneity in the effect of vitamin C on the more ill and the less ill patients with P = 0.02 and I<SUP>2</SUP> = 76% (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). The benefit of vitamin C was restricted to patients who were most severely ill when admitted to the hospital (P = 0.02). The most severely ill patients had substantially lower vitamin C plasma levels compared with the less ill patients (20 versus 26 &#956;mol/l, respectively). In the patients less ill when admitted, there was no difference in the change of respiratory scores between the trial arms (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<P>We had planned a subgroup analysis of therapeutic trials by vitamin C dosage: less and more than 1 G/day. <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> used only 0.2 G/day. One of the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> arms was lower than 1 G/day but the other arm had a range over 1 G/day and the planned subgroup analysis was thus not possible. However, the secondary analysis of the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> study suggests dose-dependency (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). The duration of recovery was reduced from 23.7 days in the control group by 4.6 days (19%) in the low-dose vitamin C arm and by 8.6 days (36%) in the high-dose vitamin C arm. Since the mean vitamin C dose in the high vitamin C arm was exactly twice the mean of the lower vitamin C arm, the linearity in dose response is striking (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>Sensitivity analysis based on the rejection of trials which were not randomised left the <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> trial as the only trial with high quality methodology. Thus, here too there was no evident trend that positive findings might be simply explained by methodological shortcomings of the trials. Both therapeutic trials used CXR when evaluating patients but neither provided a well-defined case definition of pneumonia; nor of lower respiratory tract infection in the <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> trial. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> used normalisation of CXR as one of their outcomes, which implies that changes in CXR were included in their criteria to define pneumonia.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Laboratory findings</HEADING>
<P>C-reactive protein (CRP) levels were not reported in the therapeutic studies. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> reported the proportion of participants who had normalisation of erythrocyte sedimentation rate within 16 days (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. CXR changes and body temperature changes during treatment</HEADING>
<P>
<LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> reported the proportion of participants with normalisation of the CXR in 10 days and with no fever after seven days (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Secondary analyses</HEADING>
<P>As a secondary analysis we present the results of the three arms of the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> trial in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. The control arm did not receive placebo. Mochalkin reported the proportion of participants who had normalisation of erythrocyte sedimentation rate, who had no fever after seven days and who had normalisation of the CXR in 10 days. For each outcome, the vitamin C arms fared significantly better than the control arm. The number needed to treat to benefit (NNTB) was around two to five for the three outcomes compared to the control group (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Preventing hospital-acquired pneumonia</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Incidence of pneumonia</HEADING>
<P>
<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> reported the incidence of pneumonia within two weeks in severely burned patients after one day of vitamin C administration. No difference between the groups was seen (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). However, vitamin C levels had returned to normal within three days and the confidence intervals are wide; the study is therefore not informative.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Treating hospital-acquired pneumonia</HEADING>
<P>We did not identify any trials giving information on the effect of vitamin C in treating hospital-acquired pneumonia.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-08-07 19:41:45 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>We identified three prophylactic trials which recorded 37 cases of community-acquired pneumonia in 2335 people, two therapeutic trials involving 197 community-acquired pneumonia patients and one prophylactic trial recording 13 cases of hospital-acquired pneumonia in 37 patients. The studies on community-acquired pneumonia found a benefit of vitamin C but the trial on hospital-acquired pneumonia did not. One prophylactic and one therapeutic trial on community-acquired pneumonia were satisfactorily randomised, double-blind and placebo-controlled and thus the benefits were not restricted to methodologically less satisfactory trials. However, the five community-acquired pneumonia trials with positive findings were all carried out in conditions that are far from the ordinary way of life for people living in high-income countries.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-08-07 19:41:19 +1000" MODIFIED_BY="[Empty name]">
<P>We consider that the positive findings of five analysed pneumonia trials (<LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK>; <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK>; <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK>; <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK>; <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK>) are reliable and the studies indicate a biological effect of vitamin C. However, in our view great caution is required in the extrapolation of the findings because of limitations caused by various biological factors, for example, the kind of participants used in the trials and vitamin C amounts in the diet.</P>
<SUBSECTION>
<HEADING LEVEL="3">Participants in the trials and the incidence of pneumonia</HEADING>
<P>Both <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> and <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> examined soldiers which means substantially dissimilar living conditions compared with ordinary adults. Furthermore, Kimbarowski's soldiers were hospitalised because of influenza, making them a very special group of people. <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> studied teenage boys in a UK boarding school during World War II. The age range of the <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> patients was from 66 to 94 years, obviously restricting any generalisations towards young people. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> included a wide age range of participants but their social and nutritional backgrounds were not described in the paper.</P>
<P>An important feature related to the participant selection in the prevention trials was the very high incidence of pneumonia. <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> and <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> recorded 60 and 120 cases of pneumonia per 1000 person-years in their control arms, respectively and <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> reported that 10% of their control arm became sick with pneumonia within one week after hospitalisation because of influenza.</P>
<P>In the ordinary middle-aged Western population, the incidence of pneumonia is one to three per 1000 person-years (<LINK REF="REF-Baik-2000" TYPE="REFERENCE">Baik 2000</LINK>; <LINK REF="REF-Hemil_x00e4_-2004b" TYPE="REFERENCE">Hemilä 2004b</LINK>). In contrast, in military recruits much higher rates of pneumonia have been reported. The average incidence of pneumonia in marine and naval recruits in the 1970s was 60 per 1000 person-years in a US study (<LINK REF="REF-Pazzaglia-1983" TYPE="REFERENCE">Pazzaglia 1983</LINK>) which is of the same magnitude as the pneumonia rates in the <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> and <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trials. Thus, the high incidence of pneumonia makes the conditions of all the three prevention trials very special and limits generalisations of their results. Nevertheless, the consistency in positive findings indicates that vitamin C may influence pneumonia risk in some groups of people.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Vitamin C dose in diet and supplements</HEADING>
<P>An issue of great importance in the interpretation of vitamin C supplementation trials is the level of vitamin C intake in the diet and in the supplements. A different outcome between vitamin C and control arms may result from a very low dietary intake in the control arm ('marginal vitamin C deficiency') or from the high-dose supplementation in the vitamin C arm. In the former case, a small dosage of supplement might produce a similar effect, whereas in the latter case the large dose is essential. As reference levels, scurvy may be caused by vitamin C intakes of less than 10 mg/day, whereas the mean vitamin C intake in the USA is about 100 mg/day (<LINK REF="REF-IOM-2000" TYPE="REFERENCE">IOM 2000</LINK>). Previously, a low dietary vitamin C intake level was proposed to explain the reduction in common cold incidence by vitamin C in a set of trials with UK males receiving vitamin C supplementation (<LINK REF="REF-Hemil_x00e4_-1997b" TYPE="REFERENCE">Hemilä 1997b</LINK>; <LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>).</P>
<P>
<LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> estimated that their participants got only 10 to 15 mg/day of vitamin C in their diet, so that the baseline intake was close to scurvy levels. <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> and <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> carried out their studies in the former Soviet Union and it seems highly unlikely that their diet was rich in vitamin C. <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> reported overall low plasma levels of vitamin C and the benefit of vitamin C was restricted to the most ill patients who had particularly low vitamin C levels at the baseline: only 20 &#956;mol/L (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). In the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> trial, plasma vitamin C level dropped to 23 &#956;mol/L during the hospital stay in the control group, whereas vitamin C level remained at 43 &#956;mol/L in the high vitamin C dose group. Thus, in these trials control participants may have been suffering from 'marginal vitamin C deficiency'. Low vitamin C levels are not rare in Western hospital patients nor in the Western general community (for example <LINK REF="REF-Mosd_x00f8_l-2008" TYPE="REFERENCE">Mosdøl 2008</LINK>; <LINK REF="REF-Raynaud_x002d_Simon-2010" TYPE="REFERENCE">Raynaud-Simon 2010</LINK>; <LINK REF="REF-Schleicher-2009" TYPE="REFERENCE">Schleicher 2009</LINK>). Thus, if pneumonia risk is increased by low intakes of vitamin C, this issue may be important also in high-income communities and not just in low-income countries.</P>
<P>The explanation based on 'marginal deficiency' is not applicable to the <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trial with US marine recruits, which reported high baseline vitamin C levels. In the Pitt trial, the baseline plasma vitamin C level was 56 &#956;mol/L, which corresponds to a dietary intake of 100 mg/day or more (<LINK REF="REF-Levine-1996" TYPE="REFERENCE">Levine 1996</LINK>). Thus, low dietary vitamin C intake does not explain the benefits of supplementation in the <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trial. Furthermore, this trial used the highest vitamin C dose of the five trials: 2 G/day.</P>
<P>The explanation of 'marginal deficiency' is also not applicable to the comparison between the two vitamin C arms of the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> trial. The dose-dependency over the three arms of the Mochalkin trial indicates that the therapeutic effect of vitamin C supplementation was not just limited to treating 'marginal deficiency' (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). If the vitamin C effect simply alleviated the marginal deficiency, we would not expect difference between the two vitamin C doses. An indication of linear dose-dependency up to 6 G/day of vitamin C was also found in a common cold trial by <LINK REF="REF-Karlowski-1975" TYPE="REFERENCE">Karlowski 1975</LINK> (see also <LINK REF="REF-Hemil_x00e4_-1999a" TYPE="REFERENCE">Hemilä 1999a</LINK>; <LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Physical activity</HEADING>
<P>Participants of the <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trial were marine recruits in a training camp, which means heavy physical activity. There is much evidence that physical activity increases the generation of reactive oxygen species (<LINK REF="REF-Powers-2008" TYPE="REFERENCE">Powers 2008</LINK>) and, in an electron spin resonance study, the administration of vitamin C prevented exercise-induced oxidative stress (<LINK REF="REF-Ashton-1999" TYPE="REFERENCE">Ashton 1999</LINK>). Therefore an increased intake of vitamin C might be beneficial for physically stressed people. In support of this view, vitamin C halved the risk of the common cold in five trials with participants under heavy acute physical stress (<LINK REF="REF-Hemil_x00e4_-1996" TYPE="REFERENCE">Hemilä 1996</LINK>; <LINK REF="REF-Hemil_x00e4_-2013a" TYPE="REFERENCE">Hemilä 2013a</LINK>) and halved the exercise-induced FEV<SUB>1</SUB> decline in three trials with participants who suffered from exercise-induced bronchoconstriction (<LINK REF="REF-Hemil_x00e4_-2013b" TYPE="REFERENCE">Hemilä 2013b</LINK>). It is also worth noting that vitamin E, a lipid-soluble antioxidant which interacts with vitamin C, significantly reduced the incidence of pneumonia in middle-aged males who carried out leisure time exercise but had no effect on sedentary men, which also indicates that physical activity may modify the effects of antioxidants (<LINK REF="REF-Hemil_x00e4_-2011a" TYPE="REFERENCE">Hemilä 2011a</LINK>).</P>
<P>Thus, it is probable that the heavy physical training of the military recruits of the <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trial is the reason why the high-dose vitamin C supplementation was beneficial for the participants of that trial, but the findings should not be extrapolated to a sedentary population. Several trials with military personnel have found benefit of vitamin C against respiratory infections, which may be explained by heavy physical activity and also by crowded accommodations (<LINK REF="REF-Hemil_x00e4_-2004a" TYPE="REFERENCE">Hemilä 2004a</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Diagnosis of pneumonia</HEADING>
<P>
<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> combined the cases of acute bronchitis and pneumonia together. In young people, acute bronchitis usually has a viral aetiology, whereas the majority of pneumonia cases are caused by bacteria. However, <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> patients were all over 60 years of age and their acute bronchitis was "often acute exacerbation of chronic bronchitis", implying bacterial aetiology. The clinical definition of pneumonia is soft and chest X-ray (CXR) has a substantial proportion of false negatives. For such reasons the combined outcome used in the <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> trial was appropriate in the current review.</P>
<P>There is no unambiguous clinical definition of pneumonia and this evidently limits the applicability of any studies on pneumonia. See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Hospital-acquired pneumonia</HEADING>
<P>
<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> administered vitamin C for one day only but recorded pneumonia cases for two weeks. Thus, the follow-up was substantially longer than the vitamin C administration. Furthermore, the confidence interval is wide and does not refute benefits. We consider that this trial is not informative about the potential effects of vitamin C on hospital-acquired pneumonia.</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-08-07 19:41:25 +1000" MODIFIED_BY="[Empty name]">
<P>In this section we focus on the five trials with positive findings; we briefly comment on the <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> trial at the end of this section.</P>
<P>Two of the five positive trials were placebo-controlled, randomised trials, whereas the other three trials were technically deficient to varying degrees. Here we consider whether potential biases could explain the differences between the vitamin C and control groups.</P>
<P>The concept of <B>publication bias</B> is based on an assumption that researchers tend to report a study if the result is 'positive' and tend to leave it unreported if the result is 'negative'. With this reasoning, it might be possible that the five trials analysed in this review were published just because of the significant benefit of vitamin C, whereas there might be several trials unpublished because of their negative results. However, the three papers reporting on the prophylactic effect of vitamin C were published separately from the vitamin C effects on pneumonia; the effect on pneumonia was not the motive for publication. <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> was mainly interested in the common cold and tonsillitis and the effect on pneumonia was mentioned as a secondary issue, indicating that this finding was not the reason for publication. <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> considered pneumonia as a nuisance in their trial as they focused on a chemical test. They did not pay any attention to the substantial difference in the occurrence of pneumonia in the trial arms and, for example, in their summary the pneumonia cases in both trial arms were combined. <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> focused on the common cold and pneumonia was a secondary outcome which was reported in the text but not in the abstract. Thus publication bias cannot explain this set of three prophylactic trials. Low interest in the effect of vitamin C on pneumonia is also relevant when considering detection bias (see below).</P>
<P>
<LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> found that the effect of vitamin C was limited to the patients with the lowest vitamin C levels and <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> found a linear dose-response relation in the two vitamin C arms compared with the control group (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Neither Hunt nor Mochalkin put proper emphasis on these findings and thus they were not the reason for publication. Publication bias is not a reasonable explanation for the reported positive findings.</P>
<P>
<B>Selection bias</B> means that there are systematic differences in the compared groups at baseline. In prophylactic trials, there is a low possibility of bias caused by baseline differences between the treatment arms. Maldistribution of a strong risk factor, such as smoking in a study on lung cancer, would lead to erroneous conclusions on less important risk factors. However, cohort studies have not identified strong risk factors for community-acquired pneumonia, with the age of the person being the most important factor (<LINK REF="REF-Baik-2000" TYPE="REFERENCE">Baik 2000</LINK>; <LINK REF="REF-Hemil_x00e4_-2004b" TYPE="REFERENCE">Hemilä 2004b</LINK>). Thus, to explain an 80% or greater reduction in the incidence of pneumonia in the vitamin C arms (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) there should be spectacular maldistribution in a strong risk factor for pneumonia. Furthermore, the <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trial was randomised and double-blind and <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> used pre-formed divisions and explicitly considered that the groups of were similar. In the <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> trial, the severity of influenza probably was the most important risk factor for the occurrence of pneumonia but it was distributed evenly between the trial arms.</P>
<P>In therapeutic trials, the baseline severity of disease is a factor of obvious importance. The <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> trial was randomised and allocation was concealed. Furthermore, the distribution of 'acute bronchitis' and 'bronchopneumonia' and the proportion of 'most severely ill' were closely similar in the treatment arms. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> did not describe the distribution of pneumonia severity but antibiotic treatments were distributed evenly in the three arms, so that if the selection of antibiotics depended on the clinical symptoms they were also divided evenly. Thus, it seems unlikely that systematic baseline differences between the trial arms would explain the benefits observed in the vitamin C arms.</P>
<P>
<B>Performance bias</B> means systematic differences in the care provided, apart from the intervention being evaluated. The <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> and <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trials were double-blinded. According to the <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK> description, the boys in different divisions were treated equally. <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> stated that the participants received the same diet which is obviously essential in a vitamin C study but otherwise the similarity of other treatments was not mentioned. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> stated that all patients were tested under equal conditions of placement, care and nutrition and, as noted above, the use of antibiotics was similar in the treatment arms. Although Mochalkin did not use a placebo in the control group, performance bias does not reasonably explain the difference between the two vitamin C arms (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Furthermore, given the significant difference between the two vitamin C groups, it is not reasonable to assume that the difference between the control group and the low-dose vitamin C group is caused by factors other than vitamin C. Such an explanation would presuppose that low vitamin C levels are ineffective and there is a threshold dose over which vitamin C starts to be effective. Such a dose-response model would be opposite to the findings of many studies, indicating that in many cases the benefits are more pronounced in the low-dose region (see above section 'Vitamin C dose in diet and supplements').</P>
<P>Thus, in two trials there was good evidence that participants were treated equally except for the vitamin C supplementation and in the other trials there was no explicit reason to assume that the other treatments would substantially differ between the trial arms.</P>
<P>
<B>Attrition bias</B> means high or divergent drop-out proportions and does not seem to be a substantial concern in these five trials. The three trials examining the preventive effect of vitamin C were carried out within military organisations or in a boarding school. Such a background and the descriptions in the papers did not suggest a considerable drop-out problem. <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> stated that 22% of the initial population were removed from their platoons or did not continue to take their pills and were not included in the final analysis, but the drop-outs were distributed evenly in the treatment arms. <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> followed up the patients for four weeks and did not report any drop-outs. <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> did not comment on drop-outs but the distribution of antibiotic usage was even in the trial arms, which would seem to exclude any drop-outs.</P>
<P>
<B>Detection bias</B> means systematic differences in outcome assessment. The <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> and <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trials were double-blinded and bias caused by the knowledge of participants or investigators was unlikely to have affected the outcome assessment. As noted above, in the <LINK REF="STD-Glazebrook-1942" TYPE="STUDY">Glazebrook 1942</LINK>, <LINK REF="STD-Kimbarowski-1967" TYPE="STUDY">Kimbarowski 1967</LINK> and <LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> trials, pneumonia was a secondary issue and it is unlikely that under such conditions the investigators would have any tendency to diagnose pneumonia differently in the trial arms. The <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> report did not allow any direct or indirect conclusions on the possibility of detection bias.</P>
<P>Even though three of the trials with positive results were methodologically less satisfactory in comparison with modern trial standards, the positive findings of these three trials are not easily explained by biases.</P>
<P>
<LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> trial was poorly described and the allocation method and level of blinding are not clear from the study report. Nevertheless, we would not ignore the trial on the basis of these methodological shortcomings. Vitamin C was administered for one day only but the pneumonia cases were recorded for two weeks. In addition the confidence interval is wide and does not preclude benefits. We consider that these issues make the study uninformative about the role of vitamin C on hospital-acquired pneumonia.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-07-15 12:09:06 +1000" MODIFIED_BY="[Empty name]">
<P>Our search of databases for trials meeting the criteria for our review was exhaustive but we also read reference lists of several reviews, such as <LINK REF="REF-Briggs-1984" TYPE="REFERENCE">Briggs 1984</LINK>, which contained 413 references to papers related to vitamin C and infections. Although there might be unpublished trials or trials published in very difficult to access journals or books, it seems unlikely that we could have missed large controlled trials.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-08-07 19:41:45 +1000" MODIFIED_BY="[Empty name]">
<P>Although the proponents of evidence-based medicine argue that "if you find that the study was not randomised, we'd suggest that you stop reading it and go on to the next article" (<LINK REF="REF-Sackett-1997" TYPE="REFERENCE">Sackett 1997</LINK>) we consider that cohort studies can give an important perspective to the relation between vitamin C intake and pneumonia risk.</P>
<P>A cohort study found no association between vitamin C intake and community-acquired pneumonia in middle-aged men in the USA (<LINK REF="REF-Merchant-2004" TYPE="REFERENCE">Merchant 2004</LINK>). However, there are substantial differences between this cohort study and the three prophylactic trials in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>. <LINK REF="REF-Merchant-2004" TYPE="REFERENCE">Merchant 2004</LINK> investigated male US health professionals of 40 to 75 years of age, the selection of which meant a population with a much greater than average interest in factors that affect health and whose working conditions are quite sedentary. In Merchant's cohort, the median vitamin C intake of the lowest quintile was 95 mg/day and the overall median was 218 mg/day, whereas the overall median of the ordinary US population is about 100 mg/day (<LINK REF="REF-IOM-2000" TYPE="REFERENCE">IOM 2000</LINK>). Thus vitamin C intake in Merchant's cohort was substantially higher than in the three prophylactic trials analysed in this review and the living conditions were very different compared with the three trials. Furthermore, pneumonia incidence was three cases per 1000 person-years. Thus, the Merchant cohort study indicates that the level of vitamin C intake does not affect pneumonia risk in sedentary, health-conscious, middle-aged, upper class populations when the dietary vitamin C intake is over 100 mg/day. Still, their findings cannot be extrapolated to substantially different population groups such as those in the three prophylactic trials analysed in the current review. Nevertheless, the Merchant cohort study sets certain limits to the putative generalisations of the analysed trials. Thus, we consider that biological differences, rather than methodological differences, are the most appropriate explanations for the divergence in the role of vitamin C in <LINK REF="REF-Merchant-2004" TYPE="REFERENCE">Merchant 2004</LINK> and the intervention trials in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<P>Some further trials also are relevant to the current topic. <LINK REF="STD-Dahlberg-1944" TYPE="STUDY">Dahlberg 1944</LINK> reported respiratory infections which were more severe than the common cold in military recruits (five in the vitamin C group, 10 in the control group of the same size; risk ratio (RR) 0.5, 95% confidence interval (CI) 0.2 to 1.5) but their outcome included otitis and sinusitis and not just lower respiratory infections.</P>
<P>
<LINK REF="STD-Nathens-2002" TYPE="STUDY">Nathens 2002</LINK> reported that in critically ill intensive care unit (ICU) patients vitamin C and E combination had no effect on pneumonia risk (RR 0.79, 95% CI 0.53 to 1.20). However, patients in the vitamin C and E group required 0.9 days (95% CI 0.6 to 1.2 days) less mechanical ventilatory support and had a 1.2 day (95% CI 0.81 to 1.5 days) reduction in their ICU length of stay, indicating benefits of antioxidant supplementation. However, the role of vitamin C <I>per se</I> is ambiguous and the benefit was for an outcome not directly linked to infection, even though a longer ICU stay is associated with a greater risk of pneumonia. In their trial with severe burn patients, <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK> found a 43% (P = 0.03) reduction in the duration of mechanical ventilation and a significant decrease in infusion fluid volumes from one-day, large-dose vitamin C administration, even though the incidence of hospital-acquired pneumonia was not influenced (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
<P>
<LINK REF="STD-Mahalanabis-2006a" TYPE="STUDY">Mahalanabis 2006a</LINK> reported that 400 mg vitamin E and 200 mg vitamin C per day had no therapeutic effect on 2 to 35-month old children with severe acute lower respiratory infection. However, the vitamin E dose was very high for children of this age; for example in the ATBC Study it was 50 mg/day for middle-aged males (<LINK REF="REF-Hemil_x00e4_-2004b" TYPE="REFERENCE">Hemilä 2004b</LINK>). Thus, <LINK REF="STD-Mahalanabis-2006a" TYPE="STUDY">Mahalanabis 2006a</LINK> does not allow any specific conclusions on the possible role of vitamin C.</P>
<SUBSECTION>
<HEADING LEVEL="2">Safety of vitamin C</HEADING>
<P>
<LINK REF="STD-Pitt-1979" TYPE="STUDY">Pitt 1979</LINK> administered 2 G/day of vitamin C to 331 participants for two months. None of the reported symptoms that participants thought to be caused by the pills were statistically more frequent in the vitamin C than in the placebo arm. Urticaria developed in one recruit in the vitamin C arm which subsided when the pills were withheld and recurred when he resumed taking his pills. He was instructed to stop taking pills and was excluded from the final analysis. The other trials used lower vitamin C doses and are uninformative on the safety of high vitamin C doses.</P>
<P>In general, vitamin C is considered safe in doses up to several grams per day and although there has been speculation about potential harms of large doses this has been shown to be unfounded (<LINK REF="REF-Hathcock-2005" TYPE="REFERENCE">Hathcock 2005</LINK>; <LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>; <LINK REF="REF-Rivers-1987" TYPE="REFERENCE">Rivers 1987</LINK>). For example, in a pharmacokinetic study, participants were administered up to 100 G of vitamin C intravenously within a few hours without any reported adverse effects, indicating the safety of such a large dose in healthy people (<LINK REF="REF-Padayatty-2004" TYPE="REFERENCE">Padayatty 2004</LINK>). <LINK REF="REF-Cathcart-1981" TYPE="REFERENCE">Cathcart 1981</LINK> reported that he had administered orally over 100 G per day of vitamin C to pneumonia patients, which indicates the safety of such high doses for pneumonia patients, although such an uncontrolled observation does not provide evidence of benefit. Large doses of vitamin C have also been administered intravenously for numerous patients without adverse effects (<LINK REF="REF-Padayatty-2010" TYPE="REFERENCE">Padayatty 2010</LINK>).</P>
<P>Two large-scale trials with 8171 female health professionals and 14,641 male physicians found no adverse effects of 0.5 G/day of vitamin C when administered for eight to nine years, indicating the long-term safety of such a dosage level (<LINK REF="STD-Cook-2007" TYPE="STUDY">Cook 2007</LINK>; <LINK REF="STD-Sesso-2008" TYPE="STUDY">Sesso 2008</LINK>).</P>
<P>There are few reports of severe harm caused by high-dose vitamin C administration and the death of a 68-year old African American man was not attributed to intravenous injection of 80 G of vitamin C on two consecutive days <I>per se</I> but to his coincident glucose-6-phosphate dehydrogenase (G6PD) deficiency (<LINK REF="REF-Campbell-1975" TYPE="REFERENCE">Campbell 1975</LINK>). Such isolated unfortunate events have no public health importance but they indicate that people with G6PD should avoid large doses of vitamin C.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Mechanism of effect</HEADING>
<P>Our review is largely based on the concept that vitamin C affects the immune system, which explains the protection from infections in animals (<LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>). Such immune system effects are plausible explanations for the benefits observed in the prophylactic trials (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). However, vitamin C also has non-immune effects that may be relevant in therapeutic trials.</P>
<P>Vitamin C participates in the synthesis of norepinephrine and a series of neuropeptides (<LINK REF="REF-Rice-2000" TYPE="REFERENCE">Rice 2000</LINK>) and carnitine which participates in energy metabolism (<LINK REF="REF-Hughes-1988" TYPE="REFERENCE">Hughes 1988</LINK>; <LINK REF="REF-Jones-1982" TYPE="REFERENCE">Jones 1982</LINK>). In a study of experimentally induced vitamin C deficiency, <LINK REF="REF-Kinsman-1971" TYPE="REFERENCE">Kinsman 1971</LINK> compared high and low levels of vitamin C in whole blood (93 &#956;mol/L and 25 &#956;mol/L) and found that "scores in the neurotic triad of the Minnesota Multiphasic Personality Inventory (the hypochondriasis, depression and hysteria scales) became elevated as deficiency of vitamin C progressed". Therefore, it is possible that in a therapeutic setting the influence of vitamin C is not limited to the immune system. Vitamin C levels in whole blood are higher than plasma levels and thus Kinsman's levels cannot be directly compared with the low plasma levels reported by <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> and <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> (ca 20 &#956;mol/L). Still, low vitamin C levels might cause psychological symptoms, for which vitamin C supplementation might be beneficial. Some of the early case reports of pneumonia patients described particularly rapid benefits of vitamin C (<LINK REF="REF-Bohnholtzer-1937" TYPE="REFERENCE">Bohnholtzer 1937</LINK>; <LINK REF="REF-Dalton-1962" TYPE="REFERENCE">Dalton 1962</LINK>; <LINK REF="REF-Hochwald-1937" TYPE="REFERENCE">Hochwald 1937</LINK>; <LINK REF="REF-Klenner-1948" TYPE="REFERENCE">Klenner 1948</LINK>) and such rapid benefits might be caused by non-immunological effects of vitamin C, rather than by immunological mechanisms.</P>
<P>Consistent with the concept that vitamin C might have an influence on general well-being, a recent study reported that vitamin C administration improved the mood of acutely hospitalised patients (<LINK REF="REF-Zhang-2011" TYPE="REFERENCE">Zhang 2011</LINK>). It is noteworthy that in the <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> trial the vitamin C level dropped by 44% in 10 days in the control group (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>), consistent with other studies that have found reductions in vitamin C levels with infections (<LINK REF="REF-Hemil_x00e4_-2006" TYPE="REFERENCE">Hemilä 2006</LINK>). Neither <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK> nor <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK> measured any index of general well-being or psychological status.</P>
</SUBSECTION>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-08-07 19:41:57 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-08-07 19:41:52 +1000" MODIFIED_BY="Liz Dooley">
<P>Vitamin C is relatively cheap and it is safe in doses of grams per day. Nevertheless, with the current evidence there is no basis for the prophylactic use of vitamin C to prevent pneumonia because it would require continuous supplementation with poorly understood effects.</P>
<P>While waiting for new trials, therapeutic vitamin C supplementation may be reasonable for patients with pneumonia who have low vitamin C plasma levels, since therapeutic administration is limited in time. With the low price of vitamin C, the cost-benefit ratio may be reasonable even if the benefit might be substantially lower than that observed in the therapeutic trials analysed in this review.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-08-07 19:41:57 +1000" MODIFIED_BY="[Empty name]">
<P>The incidence of pneumonia is low in the middle-aged population in Western countries (1 to 3 per 1000 person-years) and there is no rationale for studying the prophylactic effect of vitamin C in such a population. Even if vitamin C might have a small effect, the low baseline incidence would lead to a very high number needed to treat to benefit (NNTB).</P>
<P>Certain populations have a high risk of pneumonia. In low-income countries the incidence of pneumonia in children has been up to 400 cases per 1000 person-years (<LINK REF="REF-Paynter-2010" TYPE="REFERENCE">Paynter 2010</LINK>). In many low-income countries the prevalence of malnutrition is high, indicating low vitamin C intakes (<LINK REF="REF-Hemil_x00e4_-2007a" TYPE="REFERENCE">Hemilä 2007a</LINK>). Elderly people also have an elevated risk of pneumonia, since the incidence increases with age (<LINK REF="REF-Baik-2000" TYPE="REFERENCE">Baik 2000</LINK>; <LINK REF="REF-Hemil_x00e4_-2004b" TYPE="REFERENCE">Hemilä 2004b</LINK>). A further population group with a particularly high risk of pneumonia is military recruits (<LINK REF="REF-Pazzaglia-1983" TYPE="REFERENCE">Pazzaglia 1983</LINK>).</P>
<P>Even if the benefit of vitamin C was substantially lower than in the three prophylactic trials analysed in this review, the effect may still be important in populations with a high incidence of pneumonia. For example, with a baseline pneumonia incidence of 60 per 1000 person-years, a reduction of risk by half would correspond to a NNTB of 33 over one year of such a high risk.</P>
<P>In the USA, pneumonia is the sixth most common cause of death and the most common cause of infection-related mortality, reflecting its importance (<LINK REF="REF-Mandell-2010" TYPE="REFERENCE">Mandell 2010</LINK>). Therapeutic trials on vitamin C in pneumonia patients should be carried out, in particular in patients with low vitamin C plasma levels but possibly also in participants with ordinary plasma vitamin C levels. The outcomes of therapeutic trials should include soft outcomes measuring well-being because vitamin C may also have non-immune effects, especially in participants with very low plasma vitamin C levels and pneumonia <I>per se</I> leads to a substantial reduction in vitamin C levels.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-06-04 20:23:06 +1000" MODIFIED_BY="[Empty name]">
<P>English translation of the <LINK REF="REF-Gander-1936" TYPE="REFERENCE">Gander 1936</LINK> paper was kindly arranged by Eva Wintergerst from Bayer Consumer Care AG, Basel, Switzerland. English translations of the <LINK REF="REF-Bohnholtzer-1937" TYPE="REFERENCE">Bohnholtzer 1937</LINK> and <LINK REF="REF-Hochwald-1937" TYPE="REFERENCE">Hochwald 1937</LINK> papers were kindly arranged by Angelique Boyer from Proctor and Gamble Co, Cincinnati, OH.</P>
<P>We are grateful to Sharon Gudu, Anwar Merchant, Vladimir Bakaev, Andrey Duntau, Bahi Takkouche, Lize van der Merwe and Paul Glasziou for commenting on the draft protocol, which helped us to rewrite the Methods section.</P>
<P>Finally, the authors would like to thank the following people who commented on the draft review: Ann Fonfa, Vladimir Bakaev, Andrey Duntau, Anwar Merchant, Rob Ware and Chris Del Mar.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-06-06 18:47:47 +1000" MODIFIED_BY="[Empty name]">
<P>HH planned the review, carried out the literature searches and RevMan analyses and wrote the draft of the text. HH and PL selected the included trials, extracted the data, interpreted the results and finished the text. HH updated the review and PL commented on the update.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>In our protocol we defined primary outcomes for treatment as: "the duration and severity of pneumonic episode, duration of hospital stay and death caused by pneumonia". However, "the duration of hospital stay" is one way of measuring "the duration of pneumonia" and therefore in the 2013 update we simplified the primary treatment outcomes to: "the duration and severity of pneumonic episode and death caused by pneumonia".</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2013-04-14 18:47:53 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Full text versions of references which are available either free or from the publishers' databases can be accessed via the home page of the contact author, Harri Hemilä: <A HREF="http://www.mv.helsinki.fi/home/hemila/CP">http://www.mv.helsinki.fi/home/hemila/CP</A> .</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-08-06 20:12:26 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Harri Hemilä">
<STUDY DATA_SOURCE="PUB" ID="STD-Glazebrook-1942" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Harri Hemilä" NAME="Glazebrook 1942" YEAR="1942">
<REFERENCE MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Harri Hemilä" NOTES="&lt;p&gt;Available at:&lt;/p&gt;&lt;p&gt;http://www.mv.helsinki.fi/home/hemila/CP/Glazebrook_1942_ch.pdf&lt;/p&gt;&lt;p&gt;and&lt;/p&gt;&lt;p&gt;http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199803/&lt;/p&gt;" NOTES_MODIFIED="2013-08-06 19:34:33 +1000" NOTES_MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glazebrook AJ, Thomson S</AU>
<TI>The administration of vitamin C in a large institution and its effect on general health and resistance to infection</TI>
<SO>Journal of Hygiene</SO>
<YR>1942</YR>
<VL>42</VL>
<PG>1-19</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:17:26 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:17:26 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199803/"/>
<IDENTIFIER MODIFIED="2013-04-12 01:46:17 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20475613"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunt-1994" MODIFIED="2013-06-06 18:27:48 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hunt 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-06-06 18:27:48 +1000" MODIFIED_BY="Harri Hemilä" NOTES="&lt;p&gt;Available at:&lt;/p&gt;&lt;p&gt;http://www.mv.helsinki.fi/home/hemila/CP/Hunt_1994_ch.pdf&lt;/p&gt;" NOTES_MODIFIED="2013-06-06 18:27:48 +1000" NOTES_MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunt C, Chakravorty NK, Annan G, Habibzadeh N, Schorah CJ</AU>
<TI>The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections</TI>
<SO>International Journal for Vitamin and Nutrition Research</SO>
<YR>1994</YR>
<VL>64</VL>
<NO>3</NO>
<PG>212-9</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:27:48 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:27:48 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CP/Hunt1994.pdf"/>
<IDENTIFIER MODIFIED="2013-04-12 01:45:21 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7814237"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kimbarowski-1967" MODIFIED="2013-06-10 05:39:23 +1000" MODIFIED_BY="Harri Hemilä" NAME="Kimbarowski 1967" YEAR="1967">
<REFERENCE MODIFIED="2013-06-10 05:39:23 +1000" MODIFIED_BY="Harri Hemilä" NOTES="&lt;p&gt;Available at:&lt;/p&gt;&lt;p&gt;http://www.mv.helsinki.fi/home/hemila/CP/T4.pdf&lt;/p&gt;" NOTES_MODIFIED="2013-06-10 05:39:23 +1000" NOTES_MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kimbarowski JA, Mokrow NJ</AU>
<TI>Colored precipitation reaction of the urine according to Kimbarowski as an index of the effect of ascorbic acid during treatment of viral influenza</TI>
<TO>Farbige Ausfällungsreaktion des Harns nach Kimbarowski, als index der Wirkung von Ascorbinsäure bei Behandlung der Virusgrippe</TO>
<SO>Deutsche Gesundheitswesen</SO>
<YR>1967</YR>
<VL>22</VL>
<NO>51</NO>
<PG>2413-8</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:39:23 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:39:23 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="translation http://www.mv.helsinki.fi/home/hemila/T4.pdf"/>
<IDENTIFIER MODIFIED="2013-04-12 01:44:17 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="5614915"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mochalkin-1970" MODIFIED="2013-06-10 05:39:40 +1000" MODIFIED_BY="Harri Hemilä" NAME="Mochalkin 1970" YEAR="1970">
<REFERENCE MODIFIED="2013-06-10 05:39:40 +1000" MODIFIED_BY="Harri Hemilä" NOTES="&lt;p&gt;Available at:&lt;/p&gt;&lt;p&gt;http://www.mv.helsinki.fi/home/hemila/CP/T5.pdf&lt;/p&gt;" NOTES_MODIFIED="2013-06-10 05:39:40 +1000" NOTES_MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mochalkin NI</AU>
<TI>Ascorbic acid in the complex therapy of acute pneumonia</TI>
<SO>Voenno-Meditsinskii Zhurnal</SO>
<YR>1970</YR>
<VL>9</VL>
<NO>Sep</NO>
<PG>17-21</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:39:40 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:39:40 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="translation http://www.mv.helsinki.fi/home/hemila/T5.pdf"/>
<IDENTIFIER MODIFIED="2013-04-12 01:43:20 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="5515787"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pitt-1979" MODIFIED="2013-06-04 19:39:35 +1000" MODIFIED_BY="Harri Hemilä" NAME="Pitt 1979" YEAR="1979">
<REFERENCE MODIFIED="2013-04-14 21:52:21 +1000" MODIFIED_BY="Harri Hemilä" NOTES="&lt;p&gt;Available at:&lt;/p&gt;&lt;p&gt;http://dx.doi.org/10.1001/jama.1979.03290350028016&lt;/p&gt;" NOTES_MODIFIED="2013-04-14 21:52:21 +1000" NOTES_MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pitt HA, Costrini AM</AU>
<TI>Vitamin C prophylaxis in marine recruits</TI>
<SO>JAMA</SO>
<YR>1979</YR>
<VL>241</VL>
<NO>9</NO>
<PG>908-11</PG>
<IDENTIFIERS MODIFIED="2013-04-12 01:42:09 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 01:41:45 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1001/jama.1979.03290350028016"/>
<IDENTIFIER MODIFIED="2013-04-12 01:41:24 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="368370"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tanaka-2000" MODIFIED="2013-08-06 18:06:17 +1000" MODIFIED_BY="[Empty name]" NAME="Tanaka 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-08-06 18:06:17 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S</AU>
<TI>Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study</TI>
<SO>Archives of Surgery</SO>
<YR>2000</YR>
<VL>135</VL>
<NO>3</NO>
<PG>326-31</PG>
<IDENTIFIERS MODIFIED="2013-08-06 18:06:17 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1001/archsurg.135.3.326"/>
<IDENTIFIER MODIFIED="2013-08-06 18:06:17 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10722036"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-07-15 04:50:42 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Cook-2007" MODIFIED="2013-06-04 19:41:40 +1000" MODIFIED_BY="[Empty name]" NAME="Cook 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-04 19:41:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al</AU>
<TI>A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2007</YR>
<VL>167</VL>
<NO>15</NO>
<PG>1610-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1001/archinte.167.15.1610"/>
<IDENTIFIER TYPE="PUBMED" VALUE="17698683"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dahlberg-1944" MODIFIED="2013-06-06 18:28:39 +1000" MODIFIED_BY="Harri Hemilä" NAME="Dahlberg 1944" YEAR="1944">
<REFERENCE MODIFIED="2013-06-06 18:28:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dahlberg G, Engel A, Rydin H</AU>
<TI>The value of ascorbic acid as a prophylactic against common colds</TI>
<SO>Acta Medica Scandinavica</SO>
<YR>1944</YR>
<VL>119</VL>
<PG>540-61</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:28:39 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:28:39 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CC/Dahlberg1944.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunt-1984" MODIFIED="2013-06-06 18:28:56 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hunt 1984" YEAR="1984">
<REFERENCE MODIFIED="2013-06-06 18:28:56 +1000" MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunt C, Chakravorty NK, Annan G</AU>
<TI>The clinical and biochemical effects of vitamin C supplementation in short-stay hospitalised geriatric patients</TI>
<SO>International Journal for Vitamin and Nutrition Research</SO>
<YR>1984</YR>
<VL>54</VL>
<NO>1</NO>
<PG>65-74</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:28:56 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:28:56 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CP/Hunt1984.pdf"/>
<IDENTIFIER MODIFIED="2013-04-12 01:48:18 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="6376396"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kahn-2011" MODIFIED="2013-04-12 01:49:21 +1000" MODIFIED_BY="[Empty name]" NAME="Kahn 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-04-12 01:49:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kahn SA, Beers RJ, Lentz CW</AU>
<TI>Resuscitation after severe burn injury using high-dose ascorbic acid: a retrospective review</TI>
<SO>Journal of Burn Care and Research</SO>
<YR>2011</YR>
<VL>32</VL>
<NO>1</NO>
<PG>110-7</PG>
<IDENTIFIERS MODIFIED="2013-04-12 01:49:21 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 01:49:21 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/BCR.0b013e31820aaf7f"/>
<IDENTIFIER MODIFIED="2013-04-12 01:49:00 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21131846"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mahalanabis-2006a" MODIFIED="2013-07-15 04:50:42 +1000" MODIFIED_BY="Harri Hemilä" NAME="Mahalanabis 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-04-12 02:26:09 +1000" MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahalanabis D, Basak M, Paul D, Gupta S, Shaikh S, Wahed MA, et al</AU>
<TI>Antioxidant vitamins E and C as adjunct therapy of severe acute lower-respiratory infection in infants and young children: a randomized controlled trial</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>60</VL>
<NO>5</NO>
<PG>673&#8211;80</PG>
<IDENTIFIERS MODIFIED="2013-04-12 01:52:12 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 01:52:12 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1038/sj.ejcn.1602368"/>
<IDENTIFIER MODIFIED="2013-04-12 01:51:53 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16391588"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mahalanabis-2006b" MODIFIED="2013-07-15 04:50:34 +1000" MODIFIED_BY="Liz Dooley" NAME="Mahalanabis 2006b" YEAR="2006">
<REFERENCE MODIFIED="2013-04-12 01:51:02 +1000" MODIFIED_BY="Liz Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahalanabis D, Jana S, Shaikh S, Gupta S, Chakrabarti ML, Moitra P, et al</AU>
<TI>Vitamin E and vitamin C supplementation does not improve the clinical course of measles with pneumonia in children: a controlled trial</TI>
<SO>Journal of Tropical Pediatrics</SO>
<YR>2006</YR>
<VL>52</VL>
<NO>4</NO>
<PG>302-3</PG>
<IDENTIFIERS MODIFIED="2013-04-12 01:51:02 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 01:51:02 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/tropej/fmi100"/>
<IDENTIFIER MODIFIED="2013-04-12 01:50:51 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16291830"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mochalkin-1975" MODIFIED="2013-06-06 18:29:08 +1000" MODIFIED_BY="[Empty name]" NAME="Mochalkin 1975" YEAR="1975">
<REFERENCE MODIFIED="2013-06-06 18:29:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mochalkin NI</AU>
<TI>Vitamin C requirement in patients with acute pneumonia during treatment with antibiotics</TI>
<TO>Russian</TO>
<SO>Vrachebnoe Delo</SO>
<YR>1975</YR>
<VL>9</VL>
<PG>88-92</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:29:08 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:29:08 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CP/Mochalkin1975.pdf"/>
<IDENTIFIER MODIFIED="2013-04-12 01:53:01 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1210310"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nathens-2002" MODIFIED="2013-04-18 23:20:13 +1000" MODIFIED_BY="Harri Hemilä" NAME="Nathens 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-04-18 23:20:13 +1000" MODIFIED_BY="Harri Hemilä" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al</AU>
<TI>Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients</TI>
<SO>Annals of Surgery</SO>
<YR>2002</YR>
<VL>236</VL>
<NO>6</NO>
<PG>814-22</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:20:07 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:20:07 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1422648/"/>
<IDENTIFIER MODIFIED="2013-04-12 01:55:14 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12454520"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scheunert-1949" MODIFIED="2013-06-06 18:30:01 +1000" MODIFIED_BY="Harri Hemilä" NAME="Scheunert 1949" YEAR="1949">
<REFERENCE MODIFIED="2013-06-06 18:30:01 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scheunert A</AU>
<TI>Adult requirements for vitamin C</TI>
<TO>Der Tagesbedarf des Erwachsenen an vitamin C</TO>
<SO>International Zeitschrift fur Vitaminforschung</SO>
<YR>1949</YR>
<VL>20</VL>
<PG>374-86</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:30:01 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:30:01 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CC/Scheunert1949.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sesso-2008" MODIFIED="2013-06-04 19:41:40 +1000" MODIFIED_BY="[Empty name]" NAME="Sesso 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-04 19:41:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al.</AU>
<TI>Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2008</YR>
<VL>300</VL>
<NO>18</NO>
<PG>2123-33</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1001/jama.2008.600"/>
<IDENTIFIER TYPE="PUBMED" VALUE="18997197"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wahed-2008" MODIFIED="2013-04-12 02:23:58 +1000" MODIFIED_BY="[Empty name]" NAME="Wahed 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-12 02:23:58 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wahed MA, Islam MA, Khondakar P, Haque MA</AU>
<TI>Effect of micronutrients on morbidity and duration of hospital stay in childhood pneumonia</TI>
<SO>Mymensingh Medical Journal</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>77-83</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:23:58 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:23:58 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18946457"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-08-06 20:12:26 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-08-06 20:12:26 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Akaike-2001" MODIFIED="2013-06-27 13:49:35 +1000" MODIFIED_BY="[Empty name]" NAME="Akaike 2001" TYPE="JOURNAL_ARTICLE">
<AU>Akaike T</AU>
<TI>Role of free radicals in viral pathogenesis and mutation</TI>
<SO>Reviews in Medical Virology</SO>
<YR>2001</YR>
<VL>11</VL>
<NO>2</NO>
<PG>87-101</PG>
<IDENTIFIERS MODIFIED="2013-06-17 17:33:09 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-17 17:33:01 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/rmv.303"/>
<IDENTIFIER MODIFIED="2013-06-17 17:33:09 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11262528"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Albaum-1996" MODIFIED="2013-04-18 22:19:22 +1000" MODIFIED_BY="Harri Hemilä" NAME="Albaum 1996" TYPE="JOURNAL_ARTICLE">
<AU>Albaum MN, Hill LC, Murphy M, Li YH, Fuhrman CR, Britton CA, et al</AU>
<TI>Interobserver reliability of the chest radiograph in community-acquired pneumonia</TI>
<SO>Chest</SO>
<YR>1996</YR>
<VL>110</VL>
<NO>2</NO>
<PG>343-50</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:19:22 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:19:22 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8697831"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Anderson-1973" MODIFIED="2013-04-18 22:20:37 +1000" MODIFIED_BY="Harri Hemilä" NAME="Anderson 1973" TYPE="JOURNAL_ARTICLE">
<AU>Anderson TW, Reid DBW, Beaton GH</AU>
<TI>Vitamin C and the common cold [correction of the trial data in: 1972;107(6):503-8]</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1973</YR>
<VL>108</VL>
<NO>2</NO>
<PG>133</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:20:37 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:20:37 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="4684621"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ashton-1999" MODIFIED="2013-07-05 15:59:25 +1000" MODIFIED_BY="[Empty name]" NAME="Ashton 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ashton T, Young IS, Peters JR, Jones E, Jackson SK, Davies B, et al</AU>
<TI>Electron spin resonance spectroscopy, exercise, and oxidative stress: an ascorbic acid intervention study</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1999</YR>
<VL>87</VL>
<NO>6</NO>
<PG>2032-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10601146"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baik-2000" MODIFIED="2013-04-18 22:21:20 +1000" MODIFIED_BY="Harri Hemilä" NAME="Baik 2000" TYPE="JOURNAL_ARTICLE">
<AU>Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW</AU>
<TI>A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2000</YR>
<VL>160</VL>
<NO>20</NO>
<PG>3082-8</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:21:20 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:21:20 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11074737"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bakaev-2004" MODIFIED="2013-04-15 04:38:52 +1000" MODIFIED_BY="[Empty name]" NAME="Bakaev 2004" TYPE="JOURNAL_ARTICLE">
<AU>Bakaev VV, Duntau AP</AU>
<TI>Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia</TI>
<SO>International Journal of Tuberculosis and Lung Diseases</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>2</NO>
<PG>263-6</PG>
<IDENTIFIERS MODIFIED="2013-04-15 04:38:52 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-15 04:38:52 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15139458"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Beisel-1982" MODIFIED="2013-06-10 05:39:57 +1000" MODIFIED_BY="[Empty name]" NAME="Beisel 1982" TYPE="JOURNAL_ARTICLE">
<AU>Beisel WR</AU>
<TI>Single nutrients and immunity: vitamin C</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1982</YR>
<VL>35</VL>
<NO>Suppl</NO>
<PG>423-8; 460-1</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:39:57 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:39:57 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7039295"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bhoite-2011" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NAME="Bhoite 2011" TYPE="JOURNAL_ARTICLE">
<AU>Bhoite GM, Pawar SM, Bankar MP, Momin AA</AU>
<TI>Level of antioxidant vitamins in children suffering from pneumonia</TI>
<SO>Current Pediatric Research</SO>
<YR>2011</YR>
<VL>15</VL>
<NO>1</NO>
<PG>11-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bissell-1980" MODIFIED="2013-06-10 07:26:42 +1000" MODIFIED_BY="[Empty name]" NAME="Bissell 1980" TYPE="JOURNAL_ARTICLE">
<AU>Bissell MJ, Hatie C, Farson DA, Schwarz RI, Soo WJ</AU>
<TI>Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus</TI>
<SO>Proceedings of the National Academy of Sciences of the USA</SO>
<YR>1980</YR>
<VL>77</VL>
<NO>5</NO>
<PG>2711-5</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:26:42 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:26:42 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1073/pnas.77.5.2711"/>
<IDENTIFIER MODIFIED="2013-06-10 07:26:07 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="6248860"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bloomfield-1999" MODIFIED="2013-04-18 22:23:12 +1000" MODIFIED_BY="Harri Hemilä" NAME="Bloomfield 1999" TYPE="JOURNAL_ARTICLE">
<AU>Bloomfield FH, Teele RL, Voss M, Knight DB, Harding JE</AU>
<TI>Inter- and intra-observer variability in the assessment of atelectasis and consolidation in neonatal chest radiographs</TI>
<SO>Pediatric Radiology</SO>
<YR>1999</YR>
<VL>29</VL>
<NO>6</NO>
<PG>459-62</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:23:12 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:23:12 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10369906"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bohnholtzer-1937" MODIFIED="2013-06-06 18:30:22 +1000" MODIFIED_BY="[Empty name]" NAME="Bohnholtzer 1937" TYPE="JOURNAL_ARTICLE">
<AU>Bohnholtzer E</AU>
<TI>Contribution to the question of pneumonia treatment with vitamin C</TI>
<TO>Beitrag zur Frage der Pneumoniebehandlung mit vitamin C</TO>
<SO>Deutsche Medizinische Wochenschrift</SO>
<YR>1937</YR>
<VL>63</VL>
<NO>26</NO>
<PG>1001-3</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:30:20 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:30:20 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="translation http://www.mv.helsinki.fi/home/hemila/T7.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Briggs-1984" NAME="Briggs 1984" TYPE="BOOK_SECTION">
<AU>Briggs M</AU>
<TI>Vitamin C and infectious disease: a review of the literature and the results of a randomized, double-blind, prospective study over 8 years</TI>
<SO>Recent Vitamin Research</SO>
<YR>1984</YR>
<PG>39-82</PG>
<ED>Briggs MH</ED>
<PB>CRC Press</PB>
<CY>Boca Raton, FL</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buffinton-1992" MODIFIED="2013-06-17 17:35:32 +1000" MODIFIED_BY="[Empty name]" NAME="Buffinton 1992" TYPE="JOURNAL_ARTICLE">
<AU>Buffinton GD, Christen S, Peterhans E, Stocker R</AU>
<TI>Oxidative stress in lungs of mice infected with influenza A virus</TI>
<SO>Free Radical Research Communications</SO>
<YR>1992</YR>
<VL>16</VL>
<NO>2</NO>
<PG>99-110</PG>
<IDENTIFIERS MODIFIED="2013-06-17 17:35:32 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-17 17:35:30 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1321077"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Campbell-1975" MODIFIED="2013-06-06 18:31:27 +1000" MODIFIED_BY="Harri Hemilä" NAME="Campbell 1975" TYPE="JOURNAL_ARTICLE">
<AU>Campbell GD, Steinberg MH, Bower JD</AU>
<TI>Ascorbic acid-induced hemolysis in G-6-PD deficiency [letter]</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1975</YR>
<VL>82</VL>
<NO>6</NO>
<PG>810</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:31:27 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:31:27 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CC/Campbell1975.pdf"/>
<IDENTIFIER MODIFIED="2013-04-18 22:24:17 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1138591"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cathcart-1981" MODIFIED="2013-04-18 22:24:51 +1000" MODIFIED_BY="Harri Hemilä" NAME="Cathcart 1981" TYPE="JOURNAL_ARTICLE">
<AU>Cathcart RF</AU>
<TI>Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy</TI>
<SO>Medical Hypotheses</SO>
<YR>1981</YR>
<VL>7</VL>
<NO>11</NO>
<PG>1359-76</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:24:51 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:24:51 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7321921"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cemek-2006" MODIFIED="2013-06-06 18:31:33 +1000" MODIFIED_BY="[Empty name]" NAME="Cemek 2006" TYPE="JOURNAL_ARTICLE">
<AU>Cemek M, Caksen H, Bayirolu F, Cemek F, Dede S</AU>
<TI>Oxidative stress and enzymic-non-enzymic antioxidant responses in children with acute pneumonia</TI>
<SO>Cell Biochemistry and Function</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>3</NO>
<PG>269-73</PG>
<IDENTIFIERS MODIFIED="2013-04-15 04:46:25 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-15 04:46:25 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/cbf.1220"/>
<IDENTIFIER MODIFIED="2013-04-15 04:45:54 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16634091"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chakrabarti-1955" MODIFIED="2013-04-18 22:25:25 +1000" MODIFIED_BY="[Empty name]" NAME="Chakrabarti 1955" TYPE="JOURNAL_ARTICLE">
<AU>Chakrabarti B, Banerjee S</AU>
<TI>Dehydroascorbic acid level in blood of patients suffering from various infectious diseases</TI>
<SO>Proceedings of the Society for Experimental Biology and Medicine</SO>
<YR>1955</YR>
<VL>88</VL>
<NO>4</NO>
<PG>581-3</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:25:25 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:25:25 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14371706"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Collier-2008" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NAME="Collier 2008" TYPE="JOURNAL_ARTICLE">
<AU>Collier BR, Giladi A, Dossett LA, Dyer L, Fleming SB, Cotton BA</AU>
<TI>Impact of high-dose antioxidants on outcomes in acutely injured patients [comment in: 2009;33(4):447-8]</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>2008</YR>
<VL>32</VL>
<NO>4</NO>
<PG>384-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1177/0148607108319808"/>
<IDENTIFIER TYPE="DOI" VALUE="10.1177/0148607108328520"/>
<IDENTIFIER TYPE="PUBMED" VALUE="    18596309"/>
<IDENTIFIER TYPE="PUBMED" VALUE="    19229041"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dalton-1962" MODIFIED="2013-04-18 22:26:00 +1000" MODIFIED_BY="Harri Hemilä" NAME="Dalton 1962" TYPE="JOURNAL_ARTICLE">
<AU>Dalton WL</AU>
<TI>Massive doses of vitamin C in the treatment of viral diseases</TI>
<SO>Journal of the Indiana State Medical Association</SO>
<YR>1962</YR>
<VL>55</VL>
<NO>Aug</NO>
<PG>1151-4</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:26:00 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:26:00 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="13883259"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dirlewanger-2002" MODIFIED="2013-04-18 22:26:53 +1000" MODIFIED_BY="Harri Hemilä" NAME="Dirlewanger 2002" TYPE="JOURNAL_ARTICLE">
<AU>Dirlewanger M, Krahenbuhl JD, Fanconi S, Vaudaux B, Gehri M</AU>
<TI>Community-acquired pneumonia in children aged 2 months to 5 years: application of the WHO guidelines in a developed country setting (Switzerland)</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2002</YR>
<VL>161</VL>
<NO>8</NO>
<PG>460-1</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:26:53 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:26:53 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12269258"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Doherty-1991" MODIFIED="2013-04-12 00:31:43 +1000" MODIFIED_BY="Liz Dooley" NAME="Doherty 1991" TYPE="JOURNAL_ARTICLE">
<AU>Doherty JF, Dijkhuizen MA, Wieringa FT, Moule N, Golden MHN</AU>
<TI>WHO guidelines on detecting pneumonia in children [letter]</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>338</VL>
<PG>1453-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elwood-1976" MODIFIED="2013-04-18 22:29:49 +1000" MODIFIED_BY="Harri Hemilä" NAME="Elwood 1976" TYPE="JOURNAL_ARTICLE">
<AU>Elwood PC, Lee HP, Leger AS, Baird IM, Howard AN</AU>
<TI>A randomized controlled trial of vitamin C in the prevention and amelioration of the common cold</TI>
<SO>British Journal of Preventive and Social Medicine</SO>
<YR>1976</YR>
<VL>30</VL>
<NO>3</NO>
<PG>193-6</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:29:49 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:29:49 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="788820"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-File-2003" MODIFIED="2013-04-18 22:30:40 +1000" MODIFIED_BY="Harri Hemilä" NAME="File 2003" TYPE="JOURNAL_ARTICLE">
<AU>File TM</AU>
<TI>Community-acquired pneumonia</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>362</VL>
<NO>9400</NO>
<PG>1991-2001</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:30:40 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:30:40 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14683661"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Galley-1996" MODIFIED="2013-06-20 01:52:15 +1000" MODIFIED_BY="[Empty name]" NAME="Galley 1996" TYPE="JOURNAL_ARTICLE">
<AU>Galley HF, Davies MJ, Webster NR</AU>
<TI>Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading</TI>
<SO>Free Radicals in Biology and Medicine</SO>
<YR>1996</YR>
<VL>20</VL>
<NO>1</NO>
<PG>139-43</PG>
<IDENTIFIERS MODIFIED="2013-06-20 01:52:15 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-20 01:52:15 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/0891-5849(95)02022-5"/>
<IDENTIFIER MODIFIED="2013-06-20 01:47:23 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8903690"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gander-1936" MODIFIED="2013-06-06 18:33:09 +1000" MODIFIED_BY="Jenny Bellorini" NAME="Gander 1936" TYPE="JOURNAL_ARTICLE">
<AU>Gander J, Niederberger W</AU>
<TI>Vitamin C in the treatment of pneumonia</TI>
<TO>Vitamin C in der Pneumonie-Behandlung</TO>
<SO>Munchener Medizinische Wochenschrift</SO>
<YR>1936</YR>
<VL>83</VL>
<PG>2074-7</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:33:09 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:33:09 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="translation http://www.mv.helsinki.fi/home/hemila/T1.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goetzl-1974" MODIFIED="2013-06-10 07:18:35 +1000" MODIFIED_BY="[Empty name]" NAME="Goetzl 1974" TYPE="JOURNAL_ARTICLE">
<AU>Goetzl EJ, Wasserman SI, Gigli I, Austen KF</AU>
<TI>Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1974</YR>
<VL>53</VL>
<NO>3</NO>
<PG>813-8</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:18:35 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:18:35 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1172/JCI107620"/>
<IDENTIFIER MODIFIED="2013-06-10 07:17:56 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="4273024"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Greenland-1994" MODIFIED="2013-04-12 00:39:13 +1000" MODIFIED_BY="Harri Hemilä" NAME="Greenland 1994" TYPE="JOURNAL_ARTICLE">
<AU>Greenland S</AU>
<TI>Quality scores are useless and potentially misleading [comment on: 1994;140(3):290-9]</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1994</YR>
<VL>140</VL>
<NO>3</NO>
<PG>300-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-2000" MODIFIED="2013-04-18 22:32:46 +1000" MODIFIED_BY="[Empty name]" NAME="Hamilton 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton IMJ, Gilmore WS, Benzie IFF, Mulholland CW, Strain JJ</AU>
<TI>Interactions between vitamins C and E in human subjects</TI>
<SO>British Journal of Nutrition</SO>
<YR>2000</YR>
<VL>84</VL>
<NO>3</NO>
<PG>261-7</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:32:46 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:32:46 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10967604"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hathcock-2005" MODIFIED="2013-04-18 22:33:19 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hathcock 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hathcock JN, Azzi A, Blumberg J, Blumberg J, Bray T, Dickinson A, et al</AU>
<TI>Vitamins E and C are safe across a broad range of intakes</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>4</NO>
<PG>736-45</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:33:19 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:33:19 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15817846"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-1984" MODIFIED="2013-04-16 05:14:22 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 1984" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H, Roberts P, Wikström M</AU>
<TI>Activated polymorphonuclear leucocytes consume vitamin C</TI>
<SO>FEBS Letters</SO>
<YR>1984</YR>
<VL>178</VL>
<NO>1</NO>
<PG>25-30</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:05:48 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:05:38 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/0014-5793(84)81232-6"/>
<IDENTIFIER MODIFIED="2013-04-12 02:05:48 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="6094256"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-1996" MODIFIED="2013-06-10 05:52:33 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hemilä 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress</TI>
<SO>International Journal of Sports Medicine</SO>
<YR>1996</YR>
<VL>17</VL>
<NO>5</NO>
<PG>379-83</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:52:33 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:07:38 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1055/s-2007-972864"/>
<IDENTIFIER MODIFIED="2013-06-10 05:52:33 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://hdl.handle.net/10250/7979"/>
<IDENTIFIER MODIFIED="2013-04-12 02:07:30 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8858411"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-1997a" MODIFIED="2013-07-15 04:53:39 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 1997a" TYPE="BOOK_SECTION">
<AU>Hemilä H</AU>
<TI>Vitamin C and infectious diseases</TI>
<SO>Vitamin C in Health and Disease</SO>
<YR>1997</YR>
<PG>471-503</PG>
<ED>Packer L, Fuchs J</ED>
<PB>Marcel Dekker</PB>
<CY>NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-1997b" MODIFIED="2013-07-15 04:53:33 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hemilä 1997b" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C intake and susceptibility to the common cold [comments in: 1997;78(5):857-66]</TI>
<SO>British Journal of Nutrition</SO>
<YR>1997</YR>
<VL>77</VL>
<NO>1</NO>
<PG>59-72</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:08:45 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:08:38 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1017/S0007114500002889"/>
<IDENTIFIER MODIFIED="2013-04-12 02:08:45 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9059230"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-1999a" MODIFIED="2013-07-15 04:52:21 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 1999a" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of benefit</TI>
<SO>Medical Hypotheses</SO>
<YR>1999</YR>
<VL>52</VL>
<PG>171-8</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:52:06 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:34:53 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1054/mehy.1997.0639"/>
<IDENTIFIER MODIFIED="2013-06-10 05:52:06 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://hdl.handle.net/10250/8375"/>
<IDENTIFIER MODIFIED="2013-04-18 22:34:33 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10340298"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-1999b" MODIFIED="2013-07-15 04:52:12 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hemilä 1999b" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H, Douglas RM</AU>
<TI>Vitamin C and acute respiratory infections</TI>
<SO>International Journal of Tuberculosis and Lung Disease</SO>
<YR>1999</YR>
<VL>3</VL>
<NO>9</NO>
<PG>756-61</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:09:47 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:09:17 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10488881"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2003" MODIFIED="2013-04-12 02:11:19 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hemilä 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C, respiratory infections, and the immune system</TI>
<SO>Trends in Immunology</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>11</NO>
<PG>579-80</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:11:19 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:11:10 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.it.2003.09.004"/>
<IDENTIFIER MODIFIED="2013-04-12 02:11:19 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14596879"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2004a" MODIFIED="2013-07-15 04:52:01 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2004a" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C supplementation and respiratory infections: a systematic review</TI>
<SO>Military Medicine</SO>
<YR>2004</YR>
<VL>169</VL>
<NO>11</NO>
<PG>920-5</PG>
<IDENTIFIERS MODIFIED="2013-06-17 23:48:21 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-17 23:48:21 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15605943"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2004b" MODIFIED="2013-07-15 04:51:49 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2004b" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H, Virtamo J, Albanes D, Kaprio J</AU>
<TI>Vitamin E and beta-carotene supplementation and the risk of pneumonia in male smokers</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>125</VL>
<NO>2</NO>
<PG>557-65</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:36:02 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:36:02 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14769738"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2006" MODIFIED="2013-08-06 18:12:50 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2006" TYPE="OTHER">
<AU>Hemilä H</AU>
<TI>Do vitamins C and E affect respiratory infections?</TI>
<SO>[Dissertation] University of Helsinki, Helsinki, Finland</SO>
<YR>2006</YR>
<PG>5-11,20-27,46-47,62-63</PG>
<IDENTIFIERS MODIFIED="2013-06-06 17:45:38 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 17:45:38 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://hdl.handle.net/10138/20335"/>
<IDENTIFIER TYPE="OTHER" VALUE="https://oa.doria.fi/handle/10024/1540"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2007a" MODIFIED="2013-07-15 04:54:20 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H, Louhiala P</AU>
<TI>Vitamin C may affect lung infections</TI>
<SO>Journal of the Royal Society of Medicine</SO>
<YR>2007</YR>
<VL>100</VL>
<NO>11</NO>
<PG>495-8</PG>
<IDENTIFIERS MODIFIED="2013-04-16 04:27:35 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-16 04:27:35 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1258/jrsm.100.11.495"/>
<IDENTIFIER MODIFIED="2013-04-16 04:27:25 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18048704"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2008" MODIFIED="2013-06-04 20:08:38 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2008" TYPE="COCHRANE_REVIEW">
<AU>Hemilä H, Koivula T</AU>
<TI>Vitamin C for preventing and treating tetanus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006665.pub2"/>
<IDENTIFIER TYPE="PUBMED" VALUE="18425960"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2009a" MODIFIED="2013-07-15 04:53:21 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2009a" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H, Kaprio J</AU>
<TI>Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2009</YR>
<VL>169</VL>
<NO>8</NO>
<PG>946-53</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:39:54 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:39:54 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/aje/kwn413"/>
<IDENTIFIER MODIFIED="2013-04-12 02:39:36 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19218294"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2011a" MODIFIED="2013-07-15 04:51:23 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2011a" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H, Kaprio J</AU>
<TI>Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia</TI>
<SO>Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>3</VL>
<PG>51-9</PG>
<IDENTIFIERS MODIFIED="2013-04-12 02:12:22 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:12:22 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.2147/CLEP.S16114"/>
<IDENTIFIER MODIFIED="2013-04-12 02:12:05 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21386974"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2013a" MODIFIED="2013-07-15 04:51:43 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2013a" TYPE="COCHRANE_REVIEW">
<AU>Hemilä H, Chalker E</AU>
<TI>Vitamin C for preventing and treating the common cold</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-04-12 02:00:09 +1000" MODIFIED_BY="Harri Hemilä">
<IDENTIFIER MODIFIED="2013-04-12 01:59:20 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000980.pub4"/>
<IDENTIFIER MODIFIED="2013-04-12 02:00:09 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23440782"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2013b" MODIFIED="2013-07-15 04:51:37 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2013b" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis</TI>
<SO>BMJ Open</SO>
<YR>2013</YR>
<VL>3</VL>
<PG>e002416</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1136/bmjopen-2012-002416"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hess-1920" MODIFIED="2013-06-06 18:38:07 +1000" MODIFIED_BY="Liz Dooley" NAME="Hess 1920" TYPE="BOOK_SECTION">
<AU>Hess AF</AU>
<TI>Pathology</TI>
<SO>Scurvy: Past and Present</SO>
<YR>1920</YR>
<PG>81-110. (Available: Search author=Hess at: http://chla.library.cornell.edu/ )</PG>
<PB>Lippincott</PB>
<CY>Philadelphia, PA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hess-1932" MODIFIED="2013-04-18 22:40:24 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hess 1932" TYPE="JOURNAL_ARTICLE">
<AU>Hess AF</AU>
<TI>Diet, nutrition and infection</TI>
<SO>New England Journal of Medicine</SO>
<YR>1932</YR>
<VL>207</VL>
<PG>637-48</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:40:24 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:40:24 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1056/NEJM193210132071501"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2013-04-18 22:41:06 +1000" MODIFIED_BY="Harri Hemilä" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:41:06 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:41:06 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12958120"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-06-27 13:55:28 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S, editors</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</SO>
<YR>2011</YR>
<PB>Wiley-Blackwell</PB>
<CY>Chichester</CY>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="www.cochrane-handbook.org"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hochwald-1937" MODIFIED="2013-06-06 18:39:05 +1000" MODIFIED_BY="[Empty name]" NAME="Hochwald 1937" TYPE="JOURNAL_ARTICLE">
<AU>Hochwald A</AU>
<TI>Vitamin C in the treatment of croupous pneumonia</TI>
<TO>Vitamin C in der Behandlungder kruppösen Pneumonie</TO>
<SO>Deutsche Medizinische Wochenschrift</SO>
<YR>1937</YR>
<VL>63</VL>
<NO>5</NO>
<PG>182-4</PG>
<IDENTIFIERS MODIFIED="2013-06-06 18:38:55 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-06 18:38:55 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="translation http://www.mv.helsinki.fi/home/hemila/T8.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Holley-2011" MODIFIED="2013-06-12 17:53:18 +1000" MODIFIED_BY="[Empty name]" NAME="Holley 2011" TYPE="JOURNAL_ARTICLE">
<AU>Holley AD, Osland E, Barnes J, Krishnan A, Fraser JF</AU>
<TI>Scurvy: historically a plague of the sailor that remains a consideration in the modern intensive care unit</TI>
<SO>Internal Medicine Journal</SO>
<YR>2011</YR>
<VL>41</VL>
<NO>3</NO>
<PG>283-5</PG>
<IDENTIFIERS MODIFIED="2013-06-12 17:53:18 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-12 17:53:18 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/j.1445-5994.2010.02413.x"/>
<IDENTIFIER MODIFIED="2013-06-12 17:53:02 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21426466"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hopstaken-2004" MODIFIED="2013-04-18 22:41:59 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hopstaken 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hopstaken RM, Witbraad T, van Engelshoven JMA, Dinant GJ</AU>
<TI>Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections</TI>
<SO>Clinical Radiology</SO>
<YR>2004</YR>
<VL>59</VL>
<NO>8</NO>
<PG>743-52</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:41:59 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:41:59 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15262550"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hrobjartsson-2001" MODIFIED="2013-06-06 18:39:23 +1000" MODIFIED_BY="Harri Hemilä" NAME="Hrobjartsson 2001" TYPE="JOURNAL_ARTICLE">
<AU>Hrobjartsson A, Gøtzsche PC</AU>
<TI>Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>344</VL>
<NO>21</NO>
<PG>1594-602</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:42:51 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:42:51 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11372012"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hrobjartsson-2010" MODIFIED="2013-06-06 18:40:41 +1000" MODIFIED_BY="[Empty name]" NAME="Hrobjartsson 2010" TYPE="COCHRANE_REVIEW">
<AU>Hrobjartsson A, Gotzsche PC</AU>
<TI>Placebo interventions for all clinical conditions</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-06-06 18:40:41 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2013-06-06 18:40:41 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD003974.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hughes-1988" MODIFIED="2013-04-12 00:33:57 +1000" MODIFIED_BY="Liz Dooley" NAME="Hughes 1988" TYPE="JOURNAL_ARTICLE">
<AU>Hughes RE</AU>
<TI>Ascorbic acid, carnitine and fatigue</TI>
<SO>Medical Science Research</SO>
<YR>1988</YR>
<VL>16</VL>
<PG>721-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ioannidis-2007" MODIFIED="2013-06-10 05:45:19 +1000" MODIFIED_BY="Harri Hemilä" NAME="Ioannidis 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ioannidis JP, Trikalinos TA</AU>
<TI>The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey</TI>
<SO>CMAJ</SO>
<YR>2007</YR>
<VL>176</VL>
<NO>8</NO>
<PG>1091-6</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:45:19 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:45:19 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1503/cmaj.060410"/>
<IDENTIFIER MODIFIED="2013-04-18 22:44:29 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17420491"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-IOM-2000" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Liz Dooley" NAME="IOM 2000" TYPE="BOOK_SECTION">
<AU>Institute of Medicine</AU>
<TI>Vitamin C</TI>
<SO>Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids</SO>
<YR>2000</YR>
<PG>95-185</PG>
<PB>National Academy Press</PB>
<CY>Washington DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-1982" MODIFIED="2013-04-12 00:34:04 +1000" MODIFIED_BY="Harri Hemilä" NAME="Jones 1982" TYPE="JOURNAL_ARTICLE">
<AU>Jones E, Hughes RE</AU>
<TI>Influence of oral carnitine on the body weight and survival time of avitaminotic-C guinea pigs</TI>
<SO>Nutrition Reports International</SO>
<YR>1982</YR>
<VL>25</VL>
<PG>201-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Juraschek-2012" MODIFIED="2013-06-18 06:49:07 +1000" MODIFIED_BY="[Empty name]" NAME="Juraschek 2012" TYPE="JOURNAL_ARTICLE">
<AU>Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd</AU>
<TI>Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>95</VL>
<NO>5</NO>
<PG>1079-88</PG>
<IDENTIFIERS MODIFIED="2013-06-18 06:49:07 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-18 06:49:07 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.3945/ajcn.111.027995"/>
<IDENTIFIER MODIFIED="2013-06-18 06:48:53 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22492364"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Karlowski-1975" MODIFIED="2013-04-18 22:47:57 +1000" MODIFIED_BY="[Empty name]" NAME="Karlowski 1975" TYPE="JOURNAL_ARTICLE">
<AU>Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM</AU>
<TI>Ascorbic acid for the common cold: a prophylactic and therapeutic trial</TI>
<SO>JAMA</SO>
<YR>1975</YR>
<VL>231</VL>
<PG>1038-42</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:47:57 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:47:57 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1001/jama.1975.03240220018013"/>
<IDENTIFIER MODIFIED="2013-04-18 22:47:00 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="163386"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kiekara-1996" MODIFIED="2013-04-18 22:49:00 +1000" MODIFIED_BY="[Empty name]" NAME="Kiekara 1996" TYPE="JOURNAL_ARTICLE">
<AU>Kiekara O, Korppi M, Tanska S, Soimakallio S</AU>
<TI>Radiological diagnosis of pneumonia in children</TI>
<SO>Annals of Medicine</SO>
<YR>1996</YR>
<VL>28</VL>
<PG>69-72</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:49:00 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:49:00 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8932509"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kinsman-1971" MODIFIED="2013-04-18 22:49:41 +1000" MODIFIED_BY="[Empty name]" NAME="Kinsman 1971" TYPE="JOURNAL_ARTICLE">
<AU>Kinsman RA, Hood J</AU>
<TI>Some behavioral effects of ascorbic acid deficiency</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1971</YR>
<VL>24</VL>
<PG>455-64</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:49:41 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:49:41 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="4397430"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klenner-1948" MODIFIED="2013-06-10 05:54:17 +1000" MODIFIED_BY="Harri Hemilä" NAME="Klenner 1948" TYPE="JOURNAL_ARTICLE">
<AU>Klenner FR</AU>
<TI>Virus pneumonia and its treatment with vitamin C</TI>
<SO>Southern Medicine and Surgery</SO>
<YR>1948</YR>
<VL>110</VL>
<NO>2</NO>
<PG>36-8; 46</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:54:17 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:54:17 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CP/Klenner1948.pdf"/>
<IDENTIFIER MODIFIED="2013-04-18 22:50:16 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18900646"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klenner-1951" MODIFIED="2013-06-10 05:55:18 +1000" MODIFIED_BY="Harri Hemilä" NAME="Klenner 1951" TYPE="JOURNAL_ARTICLE">
<AU>Klenner FR</AU>
<TI>Massive doses of vitamin C and the virus disease</TI>
<SO>Southern Medicine and Surgery</SO>
<YR>1951</YR>
<VL>113</VL>
<NO>4</NO>
<PG>101-7</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:55:18 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:55:18 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/CP/Klenner1951.pdf"/>
<IDENTIFIER MODIFIED="2013-04-18 22:50:56 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14855098"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lau-2006" MODIFIED="2013-04-18 22:51:42 +1000" MODIFIED_BY="Harri Hemilä" NAME="Lau 2006" TYPE="JOURNAL_ARTICLE">
<AU>Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I</AU>
<TI>The case of the misleading funnel plot</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>333</VL>
<NO>7568</NO>
<PG>597-600</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:51:42 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:51:42 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16974018"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Levine-1996" MODIFIED="2013-04-18 22:52:25 +1000" MODIFIED_BY="Liz Dooley" NAME="Levine 1996" TYPE="JOURNAL_ARTICLE">
<AU>Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al</AU>
<TI>Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance</TI>
<SO>Proceedings of the National Academy of Sciences USA</SO>
<YR>1996</YR>
<VL>93</VL>
<NO>8</NO>
<PG>3704-9</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:52:25 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:52:25 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8623000"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Li-2006" MODIFIED="2013-06-18 06:52:14 +1000" MODIFIED_BY="[Empty name]" NAME="Li 2006" TYPE="JOURNAL_ARTICLE">
<AU>Li W, Maeda N, Beck MA</AU>
<TI>Vitamin C deficiency increases the lung pathology of influenza virus-infected gulo-/- mice</TI>
<SO>Journal of Nutrition</SO>
<YR>2006</YR>
<VL>136</VL>
<NO>10</NO>
<PG>2611-6</PG>
<IDENTIFIERS MODIFIED="2013-06-18 06:52:14 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-18 06:51:36 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16988135"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Luberoff-1978" MODIFIED="2013-04-12 00:32:47 +1000" MODIFIED_BY="Harri Hemilä" NAME="Luberoff 1978" TYPE="JOURNAL_ARTICLE">
<AU>Luberoff BJ</AU>
<TI>Symptomectomy with vitamin C: a chat with Robert Cathcart, MD</TI>
<SO>Chemtech</SO>
<YR>1978</YR>
<VL>8</VL>
<PG>76-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lydersen-2009" MODIFIED="2013-04-14 18:20:00 +1000" MODIFIED_BY="[Empty name]" NAME="Lydersen 2009" TYPE="JOURNAL_ARTICLE">
<AU>Lydersen S, Fagerland MW, Laake P</AU>
<TI>Recommended tests for association in 2 x 2 tables</TI>
<SO>Statistics in Medicine</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>7</NO>
<PG>1159-75</PG>
<IDENTIFIERS MODIFIED="2013-04-14 18:20:00 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-14 18:19:47 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/sim.3531"/>
<IDENTIFIER MODIFIED="2013-04-14 18:20:00 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19170020"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mandell-2010" MODIFIED="2013-08-06 20:11:55 +1000" MODIFIED_BY="[Empty name]" NAME="Mandell 2010" TYPE="BOOK_SECTION">
<AU>Mandell GL, Bennett JE, Dolin R</AU>
<TI>Acute pneumonia</TI>
<SO>Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases</SO>
<YR>2010</YR>
<VL>1</VL>
<PG>891-916</PG>
<EN>7th</EN>
<ED>Mandell GL, Bennett JE, Dolin R</ED>
<PB>Churchill Livingstone Elsevier</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manzella-1979" MODIFIED="2013-06-13 00:01:37 +1000" MODIFIED_BY="[Empty name]" NAME="Manzella 1979" TYPE="JOURNAL_ARTICLE">
<AU>Manzella JP, Roberts NJ</AU>
<TI>Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia</TI>
<SO>Journal of Immunology</SO>
<YR>1979</YR>
<VL>123</VL>
<NO>5</NO>
<PG>1940-4</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:21:36 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:20:15 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="489966"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Melbye-1992" MODIFIED="2013-04-18 22:53:36 +1000" MODIFIED_BY="Harri Hemilä" NAME="Melbye 1992" TYPE="JOURNAL_ARTICLE">
<AU>Melbye H, Dale K</AU>
<TI>Interobserver variability in the radiographic diagnosis of adult outpatient pneumonia</TI>
<SO>Acta Radiologica</SO>
<YR>1992</YR>
<VL>33</VL>
<NO>1</NO>
<PG>79-81</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:53:36 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:53:36 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1731850"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Merchant-2004" MODIFIED="2013-04-18 22:54:20 +1000" MODIFIED_BY="Harri Hemilä" NAME="Merchant 2004" TYPE="JOURNAL_ARTICLE">
<AU>Merchant AT, Curhan G, Bendich A, Singh VN, Willett WC, Fawzi WW</AU>
<TI>Vitamin intake is not associated with community-acquired pneumonia in US men</TI>
<SO>Journal of Nutrition</SO>
<YR>2004</YR>
<VL>134</VL>
<NO>2</NO>
<PG>439-44</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:54:20 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:54:20 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14747686"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mizgerd-2006" MODIFIED="2013-06-04 20:04:14 +1000" MODIFIED_BY="[Empty name]" NAME="Mizgerd 2006" TYPE="JOURNAL_ARTICLE">
<AU>Mizgerd JP</AU>
<TI>Lung infection: a public health priority</TI>
<SO>PLoS Medicine</SO>
<YR>2006</YR>
<VL>3</VL>
<NO>2</NO>
<PG>e76</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1371/journal.pmed.0030076"/>
<IDENTIFIER TYPE="PUBMED" VALUE="16401173"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mosd_x00f8_l-2008" MODIFIED="2013-08-06 20:12:26 +1000" MODIFIED_BY="[Empty name]" NAME="Mosdøl 2008" TYPE="JOURNAL_ARTICLE">
<AU>Mosdøl A, Erens B, Brunner EJ</AU>
<TI>Estimated prevalence and predictors of vitamin C deficiency within UK's low-income population</TI>
<SO>Journal of Public Health</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>4</NO>
<PG>456-60</PG>
<IDENTIFIERS MODIFIED="2013-06-12 18:00:09 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-12 18:00:09 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/pubmed/fdn076"/>
<IDENTIFIER MODIFIED="2013-06-12 17:59:41 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18812436"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nualart-2003" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NAME="Nualart 2003" TYPE="JOURNAL_ARTICLE">
<AU>Nualart FJ, Rivas CI, Montecinos VP, Godoy AS, Guaiquil VH, Golde DW, et al</AU>
<TI>Recycling of vitamin C by a bystander effect</TI>
<SO>Journal of Biological Chemistry</SO>
<YR>2003</YR>
<VL>278</VL>
<NO>12</NO>
<PG>10128-33</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:32:17 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:32:04 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1074/jbc.M210686200"/>
<IDENTIFIER MODIFIED="2013-06-10 07:32:17 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12435736"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Packer-1979" MODIFIED="2013-04-18 22:54:47 +1000" MODIFIED_BY="Harri Hemilä" NAME="Packer 1979" TYPE="JOURNAL_ARTICLE">
<AU>Packer JE, Slater TF, Wilson RL</AU>
<TI>Direct observation of a free radical interaction between vitamin E and vitamin C</TI>
<SO>Nature</SO>
<YR>1979</YR>
<VL>278</VL>
<NO>5706</NO>
<PG>737-8</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:54:47 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:54:47 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="431730"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Padayatty-2004" MODIFIED="2013-04-18 22:55:27 +1000" MODIFIED_BY="Harri Hemilä" NAME="Padayatty 2004" TYPE="JOURNAL_ARTICLE">
<AU>Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al</AU>
<TI>Vitamin C pharmacokinetics: implications for oral and intravenous use</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2004</YR>
<VL>140</VL>
<NO>7</NO>
<PG>533-7</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:55:27 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:55:27 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15068981"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Padayatty-2010" MODIFIED="2013-06-04 19:44:32 +1000" MODIFIED_BY="[Empty name]" NAME="Padayatty 2010" TYPE="JOURNAL_ARTICLE">
<AU>Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M</AU>
<TI>Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects</TI>
<SO>PLoS One</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>7</NO>
<PG>e11414</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1371/journal.pone.0011414"/>
<IDENTIFIER TYPE="PUBMED" VALUE="20628650"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Paynter-2010" MODIFIED="2013-04-16 05:13:03 +1000" MODIFIED_BY="[Empty name]" NAME="Paynter 2010" TYPE="JOURNAL_ARTICLE">
<AU>Paynter S, Ware RS, Weinstein P, Williams G, Sly PD</AU>
<TI>Childhood pneumonia: a neglected, climate-sensitive disease?</TI>
<SO>Lancet</SO>
<YR>2010</YR>
<VL>376</VL>
<NO>9755</NO>
<PG>1804-5</PG>
<IDENTIFIERS MODIFIED="2013-04-16 03:45:44 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-16 03:45:44 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S0140-6736(10)62141-1"/>
<IDENTIFIER MODIFIED="2013-04-16 03:45:26 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21111894"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pazzaglia-1983" MODIFIED="2013-04-18 22:56:02 +1000" MODIFIED_BY="Harri Hemilä" NAME="Pazzaglia 1983" TYPE="JOURNAL_ARTICLE">
<AU>Pazzaglia G, Pasternack M</AU>
<TI>Recent trends of pneumonia morbidity in US Naval personnel</TI>
<SO>Military Medicine</SO>
<YR>1983</YR>
<VL>148</VL>
<NO>8</NO>
<PG>647-51</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:56:02 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:56:02 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="6415517"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pio-2003" MODIFIED="2013-04-18 22:56:47 +1000" MODIFIED_BY="Harri Hemilä" NAME="Pio 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pio A</AU>
<TI>Standard case management of pneumonia in children in developing countries: the cornerstone of the acute respiratory infection programme</TI>
<SO>Bulletin of the WHO</SO>
<YR>2003</YR>
<VL>81</VL>
<NO>4</NO>
<PG>298-300</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:56:47 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:56:47 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12764497"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Powers-2008" MODIFIED="2013-04-18 22:57:18 +1000" MODIFIED_BY="[Empty name]" NAME="Powers 2008" TYPE="JOURNAL_ARTICLE">
<AU>Powers SK, Jackson MJ</AU>
<TI>Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production</TI>
<SO>Physiological Reviews</SO>
<YR>2008</YR>
<VL>88</VL>
<PG>1243-76</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:57:18 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-14 20:14:28 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1152/physrev.00031.2007"/>
<IDENTIFIER MODIFIED="2013-04-18 22:57:18 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18923182"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rayment-2003" MODIFIED="2013-06-10 07:29:46 +1000" MODIFIED_BY="[Empty name]" NAME="Rayment 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rayment SJ, Shaw J, Woollard KJ, Lunec J, Griffiths HR</AU>
<TI>Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression</TI>
<SO>Biochemical and Biophysical Research Communications</SO>
<YR>2003</YR>
<VL>308</VL>
<NO>2</NO>
<PG>339-45</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:29:46 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:29:46 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S0006-291X(03)01383-4"/>
<IDENTIFIER MODIFIED="2013-06-10 07:29:10 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12901874"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Raynaud_x002d_Simon-2010" MODIFIED="2013-06-12 17:57:17 +1000" MODIFIED_BY="[Empty name]" NAME="Raynaud-Simon 2010" TYPE="JOURNAL_ARTICLE">
<AU>Raynaud-Simon A, Cohen-Bittan J, Gouronnec A, Pautas E, Senet P, et al</AU>
<TI>Scurvy in hospitalized elderly patients</TI>
<SO>Journal of Nutrition, Health and Aging</SO>
<YR>2010</YR>
<VL>14</VL>
<NO>6</NO>
<PG>407-10</PG>
<IDENTIFIERS MODIFIED="2013-06-12 17:57:17 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-12 17:57:17 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s12603-010-0032-y"/>
<IDENTIFIER MODIFIED="2013-06-12 17:55:40 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20617280"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rice-2000" MODIFIED="2013-04-18 22:57:59 +1000" MODIFIED_BY="[Empty name]" NAME="Rice 2000" TYPE="JOURNAL_ARTICLE">
<AU>Rice ME</AU>
<TI>Ascorbate regulation and its neuroprotective role in the brain</TI>
<SO>Trends in Neurological Sciences</SO>
<YR>2000</YR>
<VL>23</VL>
<PG>209-16</PG>
<IDENTIFIERS MODIFIED="2013-04-18 22:57:59 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 22:57:59 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10782126"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rivers-1987" MODIFIED="2013-06-06 18:21:43 +1000" MODIFIED_BY="[Empty name]" NAME="Rivers 1987" TYPE="JOURNAL_ARTICLE">
<AU>Rivers JM</AU>
<TI>Safety of high-level vitamin C ingestion</TI>
<SO>Annals of the New York Academy of Sciences</SO>
<YR>1987</YR>
<VL>498</VL>
<PG>445-54</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="http://www.mv.helsinki.fi/home/hemila/safety/Rivers_1987.pdf"/>
<IDENTIFIER TYPE="PUBMED" VALUE="3304071"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Robertson-1934" MODIFIED="2013-04-18 23:00:31 +1000" MODIFIED_BY="Harri Hemilä" NAME="Robertson 1934" TYPE="JOURNAL_ARTICLE">
<AU>Robertson EC</AU>
<TI>The vitamins and resistance to infection: vitamin C</TI>
<SO>Medicine</SO>
<YR>1934</YR>
<VL>13</VL>
<PG>190-206</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:00:31 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:00:31 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/00005792-193405000-00001"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ruuskanen-2011" MODIFIED="2013-06-10 05:44:27 +1000" MODIFIED_BY="Harri Hemilä" NAME="Ruuskanen 2011" TYPE="JOURNAL_ARTICLE">
<AU>Ruuskanen O, Lahti E, Jennings LC, Murdoch DR</AU>
<TI>Viral pneumonia</TI>
<SO>Lancet</SO>
<YR>2011</YR>
<VL>377</VL>
<NO>9773</NO>
<PG>1264-75</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:44:27 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:44:27 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S0140-6736(10)61459-6"/>
<IDENTIFIER MODIFIED="2013-04-18 23:01:42 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21435708"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sabin-1939" MODIFIED="2013-08-06 18:17:45 +1000" MODIFIED_BY="[Empty name]" NAME="Sabin 1939" TYPE="JOURNAL_ARTICLE">
<AU>Sabin AB</AU>
<TI>Vitamin C in relation to experimental poliomyelitis with incidental observations on certain manifestations in Macacus rhesus monkeys on a scorbutic diet</TI>
<SO>Journal of Experimental Medicine</SO>
<YR>1939</YR>
<VL>69</VL>
<NO>4</NO>
<PG>507-16</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:05:53 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:05:53 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1084/jem.69.4.507"/>
<IDENTIFIER MODIFIED="2013-06-10 07:05:49 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="www.ncbi.nlm.nih.gov/pmc/articles/PMC2133652/"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sackett-1997" NAME="Sackett 1997" TYPE="BOOK_SECTION">
<AU>Sackett DL, Richardson WS, Rosenberg W, Haynes RB</AU>
<TI>Is this evidence about a treatment valid?</TI>
<SO>Evidence-based Medicine: How to Practice and Teach EBM</SO>
<YR>1997</YR>
<PG>94</PG>
<PB>Churchill Livingstone</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schleicher-2009" MODIFIED="2013-06-12 18:07:13 +1000" MODIFIED_BY="[Empty name]" NAME="Schleicher 2009" TYPE="JOURNAL_ARTICLE">
<AU>Schleicher RL, Carroll MD, Ford ES, Lacher DA</AU>
<TI>Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES)</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2009</YR>
<VL>90</VL>
<NO>5</NO>
<PG>1252-63</PG>
<IDENTIFIERS MODIFIED="2013-06-12 18:07:13 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-12 18:07:13 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.3945/ajcn.2008.27016"/>
<IDENTIFIER MODIFIED="2013-06-12 18:06:52 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19675106"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Shapiro-1997" MODIFIED="2013-04-18 23:02:13 +1000" MODIFIED_BY="[Empty name]" NAME="Shapiro 1997" TYPE="JOURNAL_ARTICLE">
<AU>Shapiro S</AU>
<TI>Is meta-analysis a valid approach to the evaluation of small effects in observational studies?</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1997</YR>
<VL>50</VL>
<PG>223-9</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:02:13 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:02:13 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9120519"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Siegel-1975" MODIFIED="2013-06-10 07:23:53 +1000" MODIFIED_BY="[Empty name]" NAME="Siegel 1975" TYPE="JOURNAL_ARTICLE">
<AU>Siegel BV</AU>
<TI>Enhancement of interferon production by poly(rI)-poly(rC) in mouse cell cultures by ascorbic acid</TI>
<SO>Nature</SO>
<YR>1975</YR>
<VL>254</VL>
<NO>5500</NO>
<PG>531-2</PG>
<IDENTIFIERS MODIFIED="2013-06-10 07:23:53 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 07:23:53 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1038/254531a0"/>
<IDENTIFIER MODIFIED="2013-06-10 07:23:19 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1121329"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Smith-2011" MODIFIED="2013-06-12 17:44:47 +1000" MODIFIED_BY="[Empty name]" NAME="Smith 2011" TYPE="JOURNAL_ARTICLE">
<AU>Smith A, Di Primio G, Humphrey-Murto S</AU>
<TI>Scurvy in the developed world</TI>
<SO>CMAJ</SO>
<YR>2011</YR>
<VL>183</VL>
<NO>11</NO>
<PG>E752-2</PG>
<IDENTIFIERS MODIFIED="2013-06-12 17:44:47 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-12 17:44:47 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1503/cmaj.091938"/>
<IDENTIFIER MODIFIED="2013-06-12 17:44:19 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21555388"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2011" MODIFIED="2013-06-04 19:50:38 +1000" MODIFIED_BY="[Empty name]" NAME="Sterne 2011" TYPE="JOURNAL_ARTICLE">
<AU>Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al</AU>
<TI>Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>343</VL>
<PG>d4002</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:02:49 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 01:38:41 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmj.d4002"/>
<IDENTIFIER MODIFIED="2013-04-18 23:02:49 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21784880"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Swingler-1998" MODIFIED="2013-04-18 23:03:35 +1000" MODIFIED_BY="Harri Hemilä" NAME="Swingler 1998" TYPE="JOURNAL_ARTICLE">
<AU>Swingler GH, Hussay GD, Zwarenstein M</AU>
<TI>Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<NO>9100</NO>
<PG>404-8</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:03:35 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:03:35 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9482294"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Syrj_x00e4_l_x00e4_-1998" MODIFIED="2013-04-18 23:04:08 +1000" MODIFIED_BY="Harri Hemilä" NAME="Syrjälä 1998" TYPE="JOURNAL_ARTICLE">
<AU>Syrjälä H, Broas M, Suramo I, Ojala A, Lähde S</AU>
<TI>High resolution computed tomography for the diagnosis of community-acquired pneumonia</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>2</NO>
<PG>358-63</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:04:08 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:04:08 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9709887"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thomas-1978" MODIFIED="2013-04-18 23:04:35 +1000" MODIFIED_BY="Harri Hemilä" NAME="Thomas 1978" TYPE="JOURNAL_ARTICLE">
<AU>Thomas WR, Holt PG</AU>
<TI>Vitamin C and immunity: an assessment of the evidence</TI>
<SO>Clinical and Experimental Immunology</SO>
<YR>1978</YR>
<VL>32</VL>
<NO>2</NO>
<PG>370-9</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:04:35 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:04:35 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="352590"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Walker-2013" MODIFIED="2013-06-12 17:17:00 +1000" MODIFIED_BY="Harri Hemilä" NAME="Walker 2013" TYPE="JOURNAL_ARTICLE">
<AU>Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al</AU>
<TI>Global estimate of the incidence of clinical pneumonia among children under five years of age</TI>
<SO>Lancet</SO>
<YR>2013</YR>
<VL>381</VL>
<NO>9875</NO>
<PG>1405-16</PG>
<IDENTIFIERS MODIFIED="2013-06-12 17:17:00 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-12 17:17:00 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S0140-6736(13)60222-6"/>
<IDENTIFIER MODIFIED="2013-06-12 17:15:40 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23582727"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wang-1997" MODIFIED="2013-06-17 17:42:11 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 1997" TYPE="JOURNAL_ARTICLE">
<AU>Wang Y, Russo TA, Kwon O, Chanock S, Rumsey SC, Levine M</AU>
<TI>Ascorbate recycling in human neutrophils: induction by bacteria</TI>
<SO>Proceedings of the National Academy of Sciences of the USA</SO>
<YR>1997</YR>
<VL>94</VL>
<NO>25</NO>
<PG>13816-9</PG>
<IDENTIFIERS MODIFIED="2013-06-17 17:42:11 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-17 17:42:11 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9391110"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wang-2012" MODIFIED="2013-08-06 18:18:46 +1000" MODIFIED_BY="[Empty name]" NAME="Wang 2012" TYPE="COCHRANE_REVIEW">
<AU>Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A</AU>
<TI>Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2013-04-12 02:30:56 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:29:06 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009175.pub2"/>
<IDENTIFIER MODIFIED="2013-04-12 02:30:56 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23076954"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Webb-2007" MODIFIED="2013-06-10 05:43:47 +1000" MODIFIED_BY="Liz Dooley" NAME="Webb 2007" TYPE="JOURNAL_ARTICLE">
<AU>Webb AL, Villamor E</AU>
<TI>Update: effects of antioxidant and non-antioxidant vitamin supplementation on immune function</TI>
<SO>Nutrition Reviews</SO>
<YR>2007</YR>
<VL>65</VL>
<NO>5</NO>
<PG>181-217</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:43:47 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:43:47 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1301/nr.2007.may.181-217"/>
<IDENTIFIER MODIFIED="2013-04-18 23:05:14 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17566547"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WHO-1999a" MODIFIED="2013-06-04 19:46:03 +1000" MODIFIED_BY="[Empty name]" NAME="WHO 1999a" TYPE="JOURNAL_ARTICLE">
<AU>The World Health Organization (The WHO Young Infants Study Group)</AU>
<TI>Clinical prediction of serious bacterial infections in young infants in developing countries</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1999</YR>
<VL>18</VL>
<NO>Suppl 10</NO>
<PG>23-31</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10530570"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WHO-1999b" MODIFIED="2013-06-27 13:54:08 +1000" MODIFIED_BY="[Empty name]" NAME="WHO 1999b" TYPE="OTHER">
<AU>WHO</AU>
<TI>Recent outbreaks of scurvy. Scurvy and its prevention and control in major emergencies</TI>
<SO>WHO/NHD/99.11</SO>
<YR>1999</YR>
<PG>1-4 (Table 2)</PG>
<PB>WHO</PB>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="http://whqlibdoc.who.int/hq/1999/WHO_NHD_99.11.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Young-1994" MODIFIED="2013-04-18 23:06:26 +1000" MODIFIED_BY="Harri Hemilä" NAME="Young 1994" TYPE="JOURNAL_ARTICLE">
<AU>Young M, Marrie TJ</AU>
<TI>Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1994</YR>
<VL>154</VL>
<NO>23</NO>
<PG>2729-32</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:06:26 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:06:26 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7993157"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zhang-2011" MODIFIED="2013-06-10 05:42:45 +1000" MODIFIED_BY="Harri Hemilä" NAME="Zhang 2011" TYPE="JOURNAL_ARTICLE">
<AU>Zhang M, Robitaille L, Eintracht S, Hoffer LJ</AU>
<TI>Vitamin C provision improves mood in acutely hospitalized patients</TI>
<SO>Nutrition</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>5</NO>
<PG>530-3</PG>
<IDENTIFIERS MODIFIED="2013-06-10 05:42:45 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-06-10 05:42:45 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.nut.2010.05.016"/>
<IDENTIFIER MODIFIED="2013-04-18 23:06:57 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20688474"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-07-15 04:54:08 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Hemil_x00e4_-1997c" MODIFIED="2013-07-15 04:52:43 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 1997c" TYPE="JOURNAL_ARTICLE">
<AU>Hemilä H</AU>
<TI>Vitamin C intake and susceptibility to pneumonia</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>1997</YR>
<VL>16</VL>
<PG>836-7</PG>
<IDENTIFIERS MODIFIED="2013-04-18 23:09:03 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-18 23:09:03 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/00006454-199709000-00003"/>
<IDENTIFIER MODIFIED="2013-04-18 23:08:24 +1000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9306475"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2007b" MODIFIED="2013-07-15 04:54:08 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2007b" TYPE="COCHRANE_REVIEW">
<AU>Hemilä H, Louhiala P</AU>
<TI>Vitamin C for preventing and treating pneumonia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2011-04-14 11:09:31 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-04-14 11:09:31 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005532.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2009b" MODIFIED="2013-07-15 04:53:10 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2009b" TYPE="COCHRANE_REVIEW">
<AU>Hemilä H, Louhiala P</AU>
<TI>Vitamin C for preventing and treating pneumonia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-04-14 11:09:37 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-04-14 11:09:37 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005532.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hemil_x00e4_-2011b" MODIFIED="2013-07-15 04:51:13 +1000" MODIFIED_BY="[Empty name]" NAME="Hemilä 2011b" TYPE="COCHRANE_REVIEW">
<AU>Hemilä H, Louhiala P</AU>
<TI>Vitamin C for preventing and treating pneumonia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2013-04-12 02:15:15 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-12 02:15:15 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005532.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-08-07 19:33:56 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Glazebrook-1942">
<CHAR_METHODS>
<P>Allocation in groups<BR/>Quasi-placebo control, see text<BR/>Carried out in winter, duration 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>1435 schoolboys in a boarding school in the UK<BR/>335 boys in vitamin C divisions (n = 2) and 1100 in control divisions (n = 5)<BR/>Age range 15 to 20, mean 16 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="[Empty name]">
<P>Vitamin C 0.05 to 0.3 G/day added to the food in the kitchen<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of pneumonia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-04-07 12:48:57 +1000" MODIFIED_BY="Liz Dooley"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hunt-1994">
<CHAR_METHODS MODIFIED="2009-04-01 04:36:32 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomised, placebo-controlled, double-blind trial<BR/>Carried out in October to December</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-01 04:36:36 +1000" MODIFIED_BY="Jenny Bellorini">
<P>57 elderly patients: 27 males, 30 females, age range 66 to 94, mean 81 years (28 vitamin C; 29 placebo)<BR/>Hospitalised for acute bronchitis (n = 40) or pneumonia (n = 17)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="Liz Dooley">
<P>Vitamin C 0.2 G/day<BR/>Treatment for up to 4 weeks after hospitalisation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Change in a score of clinical symptoms in 4 weeks (scale 3 to 10: 3 = no symptoms, 10 = death)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-27 13:36:00 +1000" MODIFIED_BY="Liz Dooley"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Kimbarowski-1967">
<CHAR_METHODS MODIFIED="2013-07-15 12:02:52 +1000" MODIFIED_BY="[Empty name]">
<P>Allocation method not described but study arms were of similar size (112 and 114 initially)<BR/>Placebo not used<BR/>Blinding of outcome assessment not described, see text<BR/>Groups were balanced on the basis of disease severity at baseline, see text</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-01-31 01:16:10 +1000" MODIFIED_BY="Harri Hemilä">
<P>226 soldiers hospitalised for influenza A (114 vitamin C; 112 control)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="[Empty name]">
<P>Vitamin C 0.3 G/day</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-04-07 11:19:17 +1000" MODIFIED_BY="Liz Dooley">
<P>Incidence of bronchopneumonia after hospitalisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mochalkin-1970">
<CHAR_METHODS>
<P>Allocation method not described<BR/>Quasi-placebo control, see text<BR/>Antibiotic treatments were balanced in study groups</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>70 in control group, 39 in low vitamin C group and 31 in high vitamin C group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="Jenny Bellorini">
<P>High vitamin C: vitamin C 2 mg per 2000 antibiotic units<BR/>(vitamin C range: 0.5 to 1.6 G/day)<BR/>Low vitamin C (used as the placebo group in the primary comparison): vitamin C 1 mg per 2000 antibiotic units<BR/>(vitamin C range: 0.25 to 0.8 G/day)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-03-09 14:26:11 +1000" MODIFIED_BY="[Empty name]">
<P>Period of recovery<BR/>Duration of fever<BR/>Duration of chest X-ray normalisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Control group was not administered placebo and thus the primary analysis focuses on the high and low vitamin C groups.</P>
<P>We did a secondary analysis in which all 3 arms were included (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Pitt-1979">
<CHAR_METHODS MODIFIED="2009-04-01 04:37:11 +1000" MODIFIED_BY="Jenny Bellorini">
<P>Randomised, placebo-controlled, double-blind trial<BR/>Carried out in October to December, 8-week trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>674 marine recruits in a training camp in the USA (331 vitamin C; 343 placebo)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 19:33:52 +1000" MODIFIED_BY="[Empty name]">
<P>Vitamin C 2 G/day<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of pneumonia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-04-07 12:48:29 +1000" MODIFIED_BY="Liz Dooley"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tanaka-2000">
<CHAR_METHODS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Parallel-group controlled trial but possibly not randomised although the term is used. Level of blinding not described</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>37 consecutive patients with burns over 30% of their total body surface area who were admitted to the ICU within 2 h after the injury</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]">
<P>Intravenous vitamin C (66 mg/kg/h) during the 24 hours after admission (i.e. 110 G for a 70 kg person)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Incidence of pneumonia within 2 weeks (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>The keywords and abstract do not have the term 'pneumonia' and therefore this study was identified only in 2013</P>
<P>Primary focus of the study was fluid balance</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>h = hour<BR/>ICU = intensive care unit<BR/>n = number</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-08-07 19:33:56 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cook-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]">
<P>No data on pneumonia. This is a large-scale trial in which 0.5 G/d vitamin C was administered to 8171 US female health professionals for 9 y. We asked whether any data on the incidence of pneumonia might have been collected and received a reply: "WACS ... did not ask about occurrence of pneumonia" (email Dr. Cook 23 April 2013). This large-scale trial does give relevant information about adverse effects of vitamin C</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dahlberg-1944">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>Military recruits in Sweden (n = 2525). 50 mg/day of vitamin C. The outcome is a mixture of tonsillitis, otitis, sinusitis, bronchitis and pneumonia making the trial potentially relevant. However, the cases of pneumonia or lower respiratory tract infection cannot be inferred from the outcome also containing upper respiratory infections</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Hunt-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Jenny Bellorini">
<P>One group of diagnoses in the hospitalised patients (n = 199) was "respiratory infections" but it was not separated into lower and upper respiratory infections</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Kahn-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Liz Dooley">
<P>The study recorded the frequency of pneumonia in burn patients (n = 40). The abstract suggests that it was a controlled trial: "patients were divided into two groups", one of which was administered IV vitamin C. However, the text indicates that the study was not a trial but an analysis of a cohort of patients admitted to burn care unit</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Mahalanabis-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="Liz Dooley">
<P>Combination of vitamins C (0.2 G/d) and E (0.4 G/d) was used for 5 d. Children aged 2 to 35 months with severe acute lower respiratory tract infection. No difference in recovery rate between treatment (n = 89) and placebo groups (n = 85)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Mahalanabis-2006b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="Liz Dooley">
<P>Combination of vitamins C (0.2 G/d) and E (0.2 G/d) was used for 6 d. Children aged 1 to 10 y with measles and associated pneumonia; all were clinically diagnosed to have pneumonia. No difference in recovery rate between treatment (n = 36) and placebo groups (n = 35)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mochalkin-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>No placebo in the control group (n = 70). Benefit was reported in the vitamin C versus no treatment comparison (n = 70)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Nathens-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="Liz Dooley">
<P>Critically ill surgical patients (n = 595). Combination of vitamins C (1 G/d) IV and vitamin E (1000 IU/d) per naso-orogastric tube for up to 28 d. No difference in the incidence of pneumonia but significant decrease in the duration of mechanical ventilation and ICU length of stay</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Scheunert-1949">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="Liz Dooley">
<P>Different doses of vitamin C were administered to 4 study groups (20, 50, 100 and 300 mg/day) (n = 1066) so that the lowest dose arm might be used as the control group<BR/>"Lung disease" was used as one of the outcomes making the trial potentially relevant<BR/>The data are, however, presented so ambiguously that no data could be extracted for this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-07 19:33:56 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sesso-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-07 19:33:56 +1000" MODIFIED_BY="[Empty name]">
<P>No data on pneumonia. This is a large-scale trial in which 0.5 G/d vitamin C was administered to 14,641 US male physicians for 8 y. We asked whether any data on the incidence of pneumonia might have been collected and received a reply: "data on incident pneumonia has unfortunately not been collected" (email Dr. Sesso 19 April 2013). This large-scale trial does give relevant information about adverse effects</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wahed-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>The description of the methods of this 7-arm trial is minimal. The dose of vitamin C is not described. It is not clear whether a placebo was used. The authors state that "initially data was collected from 1150 children and after exclusions only 800 children were selected for analysis." However, the original number of children in each of the 7 groups is not reported. When the reasons for exclusion seem to be random (complications of pneumonia etc.) it does not seem possible that random dropping out would lead to 5 groups which each had exactly 40 children and a placebo group which had exactly 400 children. The duration of hospital stay because of pneumonia in the control group (n = 400) was 7.75 d and in the vitamin C group (n = 40) was 7.00 d. However, the SD is not given for the estimates. Due to these and many further problems we excluded the trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>d = days<BR/>ICU = intensive care unit<BR/>IV = intravenous<BR/>n = number<BR/>SD = standard deviation<BR/>y = years</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="Liz Dooley" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:04:49 +1000" MODIFIED_BY="Liz Dooley" RESULT="NO" STUDY_ID="STD-Glazebrook-1942">
<DESCRIPTION>
<P>Treatment groups were based on administrative divisions of boarding school, no allocation on individual level</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-15 12:02:51 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Hunt-1994">
<DESCRIPTION>
<P>Reported as randomised but no details of randomisation are described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-12 17:39:57 +1000" MODIFIED_BY="Liz Dooley" RESULT="NO" STUDY_ID="STD-Kimbarowski-1967">
<DESCRIPTION>
<P>Concluding from the report, probably alternative allocation because the groups were nearly identical in size (114 versus 112) though this is not explicitly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:05:46 +1000" MODIFIED_BY="Liz Dooley" RESULT="NO" STUDY_ID="STD-Mochalkin-1970">
<DESCRIPTION>
<P>Randomisation not described and groups are of such different sizes that it is unlikely they originate from randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:19:22 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Pitt-1979">
<DESCRIPTION>
<P>Participants were assigned randomly to the groups from a list of consecutive numbers randomised in pairs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-07 19:33:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanaka-2000">
<DESCRIPTION>
<P>"Randomization was performed according to the month of admission" suggests that the authors used 'randomisation' as a synonym for 'allocation'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Glazebrook-1942">
<DESCRIPTION>
<P>Concluding from the report, allocation was not concealed from the researchers but may have been from the schoolboys, although this is not explicitly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:15:26 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Hunt-1994">
<DESCRIPTION>
<P>Study was double-blind so that neither participants nor researchers knew to which group the participant had been allocated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-20 10:33:50 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kimbarowski-1967">
<DESCRIPTION>
<P>Concluding from the report, there is no reason to assume that allocation was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-20 10:34:27 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mochalkin-1970">
<DESCRIPTION>
<P>Concluding from the report, there is no reason to assume that allocation was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-07 11:15:35 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Pitt-1979">
<DESCRIPTION>
<P>Study was double-blind so that neither participants nor researchers knew to which group the participant had been allocated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-17 16:40:06 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanaka-2000">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-04-19 23:53:08 +1000" MODIFIED_BY="Harri Hemilä" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-06-17 16:40:00 +1000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-20 10:33:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Glazebrook-1942">
<DESCRIPTION>
<P>Concluding from the report, the participants were blinded to vitamin C administration (see <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK> for details)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-19 23:52:49 +1000" MODIFIED_BY="Harri Hemilä" RESULT="YES" STUDY_ID="STD-Hunt-1994">
<DESCRIPTION>
<P>Double-blind trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-20 10:34:09 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kimbarowski-1967">
<DESCRIPTION>
<P>Concluding from the report, there is no reason to assume that researchers were blinded to the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-20 10:34:35 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mochalkin-1970">
<DESCRIPTION>
<P>Concluding from the report, there is no reason to assume that researchers were blinded to the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-19 23:50:44 +1000" MODIFIED_BY="Harri Hemilä" RESULT="YES" STUDY_ID="STD-Pitt-1979">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-06-17 16:40:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanaka-2000">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2013-06-17 16:39:55 +1000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-20 10:33:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Glazebrook-1942">
<DESCRIPTION>
<P>Concluding from the report, the diagnosis of pneumonia was made in the Sick Quarter by physicians who were not involved in the study so that they probably were blinded to the treatment group (see <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK> for details)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-19 23:52:52 +1000" MODIFIED_BY="Harri Hemilä" RESULT="YES" STUDY_ID="STD-Hunt-1994">
<DESCRIPTION>
<P>Double-blind trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-20 10:38:33 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kimbarowski-1967">
<DESCRIPTION>
<P>Concluding from the report, there is no reason to assume that researchers were blinded when assessing pneumonia</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-20 10:34:38 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mochalkin-1970">
<DESCRIPTION>
<P>Concluding from the report, there is no reason to assume that researchers were blinded when assessing pneumonia</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-19 23:50:43 +1000" MODIFIED_BY="Harri Hemilä" RESULT="YES" STUDY_ID="STD-Pitt-1979">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-17 16:39:55 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanaka-2000">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-03-25 22:41:48 +1000" MODIFIED_BY="Harri Hemilä" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-03-25 22:41:48 +1000" MODIFIED_BY="Harri Hemilä" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-03-25 22:41:48 +1000" MODIFIED_BY="Harri Hemilä" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-04-12 17:40:29 +1000" MODIFIED_BY="[Empty name]">Mochalkin 1970: All results of all three trial arms</TITLE>
<TABLE COLS="5" ROWS="14">
<TR>
<TH VALIGN="BOTTOM">
<P>Outcome</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Control</P>
<P>(no placebo)</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Low C group</P>
</TH>
<TH VALIGN="BOTTOM">
<P>High C group</P>
</TH>
<TH VALIGN="BOTTOM">
<P>P</P>
<P>(High versus control)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Participants in the trial arms (N)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>70</P>
</TD>
<TD VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>31</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Vitamin C level in plasma</B>
</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Initial level (&#956;mol/L)</P>
</TD>
<TD VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>40</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Level at 10 days (&#956;mol/L)</P>
</TD>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>43</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Outcomes</B>
</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Normalisation of erythrocyte sedimentation rate in 16 days (n)</P>
</TD>
<TD>
<P>41 (58%)</P>
</TD>
<TD>
<P>36 (92%)</P>
</TD>
<TD>
<P>31 (100%)</P>
</TD>
<TD>
<P>10<SUP>-5</SUP>
</P>
</TD>
</TR>
<TR>
<TD>
<P>NNTB, compared with the control</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>3.0</P>
</TD>
<TD>
<P>2.1</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Temperature normal in 10 days (n)</P>
</TD>
<TD VALIGN="TOP">
<P>54 (77%)</P>
</TD>
<TD VALIGN="TOP">
<P>37 (95%)</P>
</TD>
<TD VALIGN="TOP">
<P>31 (100%)</P>
</TD>
<TD VALIGN="TOP">
<P>0.002</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>NNTB, compared with the control</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>5.5</P>
</TD>
<TD VALIGN="TOP">
<P>4.4</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Chest radiograph normal in 16 days (n)</P>
</TD>
<TD VALIGN="TOP">
<P>47 (67%)</P>
</TD>
<TD VALIGN="TOP">
<P>33 (84%)</P>
</TD>
<TD VALIGN="TOP">
<P>29 (93%)</P>
</TD>
<TD VALIGN="TOP">
<P>0.003</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>NNTB, compared with the control</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>5.9</P>
</TD>
<TD VALIGN="TOP">
<P>3.8</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Duration of hospital stay (days) (SD)</P>
</TD>
<TD VALIGN="TOP">
<P>23.7 (3.2)</P>
</TD>
<TD VALIGN="TOP">
<P>19.1 (4.6)</P>
</TD>
<TD VALIGN="TOP">
<P>15.1 (3.3)</P>
</TD>
<TD VALIGN="TOP">
<P>10<SUP>-20</SUP>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Difference from control, mean (95% CI)</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>4.6 (3.1 to 6.1)</P>
</TD>
<TD VALIGN="TOP">
<P>8.6 (7.2 to 10.0)</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI = confidence interval<BR/>n = number<BR/>NNTB = number need to treat to benefit<BR/>SD = standard deviation</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-08-07 19:35:29 +1000" MODIFIED_BY="Harri Hemilä">
<COMPARISON ID="CMP-001" MODIFIED="2013-08-07 19:34:57 +1000" MODIFIED_BY="Harri Hemilä" NO="1">
<NAME>Vitamin C for preventing community-acquired pneumonia</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2013-08-07 19:34:57 +1000" MODIFIED_BY="Harri Hemilä" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="78.30469222592487" SORT_BY="USER" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="780" TOTAL_2="1555" WEIGHT="0.0" Z="0.0">
<NAME>The number of pneumonia cases during the follow-up</NAME>
<GROUP_LABEL_1>Vit C</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vitamin C</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8275988058937297" CI_START="0.08635368459096224" EFFECT_SIZE="0.26733164094810047" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="17" LOG_CI_END="-0.08218014463044285" LOG_CI_START="-1.063719126962957" LOG_EFFECT_SIZE="-0.5729496357966999" ORDER="1" O_E="-3.9686411149825784" SE="0.5765608569184413" STUDY_ID="STD-Glazebrook-1942" TOTAL_1="335" TOTAL_2="1100" VAR="3.0082206693344933" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.7708667615581444" CI_START="0.07570289651917975" EFFECT_SIZE="0.24157161811833652" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.11302067995231802" LOG_CI_START="-1.1208875033502483" LOG_EFFECT_SIZE="-0.6169540916512831" ORDER="2" O_E="-4.053097345132743" SE="0.592025961085182" STUDY_ID="STD-Kimbarowski-1967" TOTAL_1="114" TOTAL_2="112" VAR="2.8531098754796775" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.9168022382311382" CI_START="0.05649284173083334" EFFECT_SIZE="0.2275802358353323" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.03772433511245535" LOG_CI_START="-1.248006578618619" LOG_EFFECT_SIZE="-0.6428654568655371" ORDER="3" O_E="-2.9287833827893177" SE="0.7109257808292473" STUDY_ID="STD-Pitt-1979" TOTAL_1="331" TOTAL_2="343" VAR="1.9785702408667205" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-08-07 19:35:23 +1000" MODIFIED_BY="Harri Hemilä" NO="2">
<NAME>Vitamin C for treating community-acquired pneumonia</NAME>
<CONT_OUTCOME CHI2="4.208723978588095" CI_END="0.3476984400808929" CI_START="-1.5765670313788753" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6144342956489912" ESTIMABLE="YES" I2="76.23982933811993" I2_Q="76.23982933811993" ID="CMP-002.01" MODIFIED="2013-08-07 19:35:09 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04021672087693695" P_Q="0.04021672087693695" P_Z="0.2106915208920752" Q="4.208723978588095" RANDOM="NO" SCALE="9.118779252923638" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="28" TOTAL_2="29" UNITS="" WEIGHT="200.0" Z="1.2516662676742696">
<NAME>Change in the severity of pulmonary symptoms (scale 3 to 10)</NAME>
<GROUP_LABEL_1>Vitamin C</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vitamin C</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.4381184312577888" CI_START="-4.321881568742211" DF="0" EFFECT_SIZE="-2.38" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2013-04-19 18:04:08 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.016298484859953312" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="15" WEIGHT="100.0" Z="2.402162087684236">
<NAME>Most severely ill (respiratory score 8 or 9 on admission)</NAME>
<CONT_DATA CI_END="-0.4381184312577888" CI_START="-4.321881568742211" EFFECT_SIZE="-2.38" ESTIMABLE="YES" MEAN_1="-4.25" MEAN_2="-1.87" MODIFIED="2013-04-14 19:19:30 +1000" MODIFIED_BY="[Empty name]" ORDER="6" SD_1="2.14" SD_2="3.0" SE="0.9907741081262335" STUDY_ID="STD-Hunt-1994" TOTAL_1="12" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0676459860239527" CI_START="-1.1476459860239527" DF="0" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" MODIFIED="2013-06-04 19:55:37 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.943573297600439" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="14" WEIGHT="100.0" Z="0.07077943708623423">
<NAME>Less ill (respiratory score 7 or less on admission)</NAME>
<CONT_DATA CI_END="1.0676459860239527" CI_START="-1.1476459860239527" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="-2.82" MEAN_2="-2.78" MODIFIED="2013-06-04 19:55:37 +1000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="1.44" SD_2="1.63" SE="0.5651358875779978" STUDY_ID="STD-Hunt-1994" TOTAL_1="16" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2013-08-07 19:35:17 +1000" MODIFIED_BY="Harri Hemilä" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="320.50141287564486" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Mortality of pneumonia patients</NAME>
<GROUP_LABEL_1>Vit C</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vitamin C</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.285581236502216" CI_START="0.04490806325261568" EFFECT_SIZE="0.24027684758465057" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.10909952512506377" LOG_CI_START="-1.3476756743258185" LOG_EFFECT_SIZE="-0.6192880746003773" ORDER="32113" O_E="-1.9473684210526314" SE="0.8557169633109855" STUDY_ID="STD-Hunt-1994" TOTAL_1="28" TOTAL_2="29" VAR="1.365650969529086" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-2.1721673974726805" CI_START="-5.827832602527323" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.000000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2013-08-07 19:35:23 +1000" MODIFIED_BY="Harri Hemilä" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="1.7935479906968118E-5" Q="0.0" RANDOM="NO" SCALE="14.341924648594375" SORT_BY="USER" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="39" UNITS="" WEIGHT="100.0" Z="4.289154229616076">
<NAME>Duration of pneumonia (days)</NAME>
<GROUP_LABEL_1>High vit C</GROUP_LABEL_1>
<GROUP_LABEL_2>Low vit C</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours high vit C</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours low vit C</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.1721673974726805" CI_START="-5.827832602527323" EFFECT_SIZE="-4.000000000000002" ESTIMABLE="YES" MEAN_1="15.1" MEAN_2="19.1" ORDER="1" SD_1="3.23" SD_2="4.56" SE="0.9325847908150515" STUDY_ID="STD-Mochalkin-1970" TOTAL_1="31" TOTAL_2="39" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-08-07 19:35:29 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Vitamin C for preventing hospital-acquired pneumonia</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.40093702266472" CI_START="0.306596620151223" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1615990774132825" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.6435451538606296" LOG_CI_START="-0.5134326370151208" LOG_EFFECT_SIZE="0.06505625842275438" METHOD="PETO" MODIFIED="2013-08-07 19:35:29 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8255475692882676" Q="0.0" RANDOM="NO" SCALE="59.81544835673608" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="18" WEIGHT="100.0" Z="0.22041550751119368">
<NAME>The number of pneumonia cases during the follow-up</NAME>
<GROUP_LABEL_1>Vitamin C</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours vitamin C</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.40093702266472" CI_START="0.306596620151223" EFFECT_SIZE="1.1615990774132825" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.6435451538606296" LOG_CI_START="-0.5134326370151208" LOG_EFFECT_SIZE="0.06505625842275438" MODIFIED="2013-06-17 16:35:26 +1000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.32432432432432456" SE="0.6796144814928466" STUDY_ID="STD-Tanaka-2000" TOTAL_1="19" TOTAL_2="18" VAR="2.1650840029218408" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-08-07 19:35:24 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-08-07 19:33:55 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAPgAAAIJCAIAAAAH4mfJAAATq0lEQVR42u3dv27lxhnG4QMYCFKo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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-08-07 19:34:58 +1000" MODIFIED_BY="Harri Hemilä" NO="2" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Prophylactic effect of vitamin C against pneumonia in three trials</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAnoAAACACAMAAACr4jRoAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-08-07 19:35:10 +1000" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Effect of vitamin C on the respiratory symptom score (scale 3 to 10) in <LINK REF="STD-Hunt-1994" TYPE="STUDY">Hunt 1994</LINK>
</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArMAAAEQCAMAAACUWQz0AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2013-08-07 19:35:24 +1000" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-002.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Effect of vitamin C on the duration of hospital stay (days) in <LINK REF="STD-Mochalkin-1970" TYPE="STUDY">Mochalkin 1970</LINK>
</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArMAAACACAMAAAAvSBEDAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-03-25 20:45:45 +1000" MODIFIED_BY="Harri Hemilä">Diagnosis of pneumonia</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>We did not require that the pneumonia diagnosis was based on chest X-radiography (CXR). CXR is objective in the sense that the picture is permanent. However, it is not an effective test for pneumonia. <LINK REF="REF-Syrj_x00e4_l_x00e4_-1998" TYPE="REFERENCE">Syrjälä 1998</LINK> reported that of 26 adult pneumonia cases that were diagnosed as pneumonia using high-resolution computed tomography (HRCT), only 18 were identified when using CXR; thus 30% of the HRCT-identified pneumonias were false negatives in the CXR. <LINK REF="REF-Doherty-1991" TYPE="REFERENCE">Doherty 1991</LINK> reported that of six cases of pneumonia in children identified at autopsy, only three were identified by a radiologist using CXR. Evidently the sensitivity of CXR is often low. Also, the interpretation of CXR to conclude that a patient has pneumonia is quite subjective. Kappa (K) score is a measure for inter-observer variability, with K = 1 indicating perfect agreement and K = 0 indicating agreement explained by pure chance. In both adults and children, interpretation of a set of CXR to decide whether the patient has pneumonia or not yielded low agreement between two observers: K of 0.4 to 0.5 (<LINK REF="REF-Albaum-1996" TYPE="REFERENCE">Albaum 1996</LINK>; <LINK REF="REF-Bloomfield-1999" TYPE="REFERENCE">Bloomfield 1999</LINK>; <LINK REF="REF-Hopstaken-2004" TYPE="REFERENCE">Hopstaken 2004</LINK>; <LINK REF="REF-Melbye-1992" TYPE="REFERENCE">Melbye 1992</LINK>) and inter-observer variability ranged from 20% to 30% (<LINK REF="REF-Kiekara-1996" TYPE="REFERENCE">Kiekara 1996</LINK>; <LINK REF="REF-Young-1994" TYPE="REFERENCE">Young 1994</LINK>). In patients with chronic obstructive pulmonary disease, <LINK REF="REF-Hopstaken-2004" TYPE="REFERENCE">Hopstaken 2004</LINK> found a K of 0.2 for the diagnosis of pneumonia using CXR indicating very poor agreement between two radiologists. Because of its inconsistency and low sensitivity, CXR is not a 'gold standard' for the diagnosis of pneumonia, even though it is a very popular method. HRCT is more sensitive but rarely available.</P>
<P>Pneumonia can be diagnosed clinically without CXR. In low-income countries, the World Health Organization (WHO) has proposed the use of respiratory rate and chest in-drawing to decide whether children presenting to outpatient clinics with cough or difficulty in breathing have 'clinical pneumonia' (<LINK REF="REF-Pio-2003" TYPE="REFERENCE">Pio 2003</LINK>). A multi-centre study facilitated by the WHO evaluated the efficacy of predicting pneumonia from clinical signs and symptoms and found that a combination of respiratory rate, rectal temperature, weight-for-age and a set of other clinical findings accurately predicted pneumonia (<LINK REF="REF-WHO-1999a" TYPE="REFERENCE">WHO 1999a</LINK>). This study was motivated by the fact that "in low-income countries laboratory facilities to perform tests such as the blood count and CXR are often unavailable and clinical decisions must be made without them". A Cochrane Review analysed whether clinical symptoms and signs might be used to identify pneumonia caused by <I>Mycoplasma pneumoniae</I> but they were not good at identifying mycoplasma pneumonia cases (<LINK REF="REF-Wang-2012" TYPE="REFERENCE">Wang 2012</LINK>).</P>
<P>Clinical diagnosis of pneumonia and CXR-based diagnosis of pneumonia have modest disagreement but we do not know how they both compare with HRCT. It is possible that some of the clinical pneumonia cases that are negative in CXR might be positive in HRCT. Thus, the divergence between clinical diagnosis and CXR should not be considered categorically as a measure of error in the former.</P>
<P>Furthermore, CXR does not necessarily add useful information to the clinical diagnosis of pneumonia. Swingler found that "interpretation of CXR did not affect clinical outcome in outpatient children with an acute lower respiratory infection. There are no clinically identifiable subgroups of children within the WHO case definition of pneumonia who are likely to benefit from a CXR" (<LINK REF="REF-Swingler-1998" TYPE="REFERENCE">Swingler 1998</LINK>). Finally, <LINK REF="REF-Dirlewanger-2002" TYPE="REFERENCE">Dirlewanger 2002</LINK> in Switzerland found that of 47 children fulfilling the WHO clinical criteria of pneumonia, 46 children had consolidation or diffuse infiltrate in CXR; thus showing that pneumonia can be accurately diagnosed clinically in high-income countries without the use of CXR. For these reasons we have not limited our review to trials using pneumonia diagnosis based on CXR but have also included trials with clinical pneumonia diagnosis.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-04-12 16:13:10 +1000" MODIFIED_BY="Harri Hemilä">Earlier searches</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-06 19:34:33 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Search in 2007 version: </B>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2006, Issue 1), OLD MEDLINE (1950 TO 1965), MEDLINE (1966 to February Week 2, 2006), EMBASE (1974 to March 2006), Web of Science (1945 to February 2006) and reference lists of reviews and articles.</P>
<SUBSECTION>
<HEADING LEVEL="4">MEDLINE (OVID)</HEADING>
<P>1 vitamin C.mp. or exp Ascorbic Acid/<BR/>2 pneumonia.mp. or exp Pneumonia/<BR/>3 bronchitis.mp. or exp Bronchitis/<BR/>4 2 or 3<BR/>5 1 and 4<BR/>
</P>
<P>
<B>Search in 2009 version:</B> We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2008, Issue 4), which contains the Acute Respiratory Infections Group's Specialised Register, Ovid MEDLINE (1950 to January  Week 1, 2009), EMBASE (1974 to January 2009), Web of Science (1945 to January 2009) and reference lists of reviews and articles. MEDLINE search as in 2007 version, see above.</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-04-12 16:09:51 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2013-04-12 16:09:51 +1000" MODIFIED_BY="[Empty name]">Embase.com search strategy in 2013</TITLE>
<APPENDIX_BODY MODIFIED="2013-04-08 13:17:41 +1000" MODIFIED_BY="[Empty name]">
<P>#13. #6 AND #12 <BR/>#12. #7 OR #8 OR #9 OR #10 OR #11 <BR/>#11. 'vit c':ab,ti <BR/>#10. 'vitamin c':ab,ti <BR/>#9. ascorb*:ab,ti <BR/>#8. 'l-ascorbic':ab,ti <BR/>#7. 'ascorbic acid'/exp <BR/>#6. #1 OR #2 OR #3 OR #4 OR #5 <BR/>#5. bronchit*:ab,ti <BR/>#4. 'bronchitis'/exp <BR/>#3. bronchopneumon*:ab,ti <BR/>#2. pneumon*:ab,ti <BR/>#1. 'pneumonia'/exp </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2013-04-12 16:10:02 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2013-04-12 16:10:02 +1000" MODIFIED_BY="[Empty name]">Web of Science search strategy in 2013</TITLE>
<APPENDIX_BODY MODIFIED="2013-04-08 13:16:45 +1000" MODIFIED_BY="[Empty name]">
<P>Topic=(pneumon* or bronchopneumon* or bronchit*) AND Topic=("ascorbic acid" or "vitamin c" or "vit c")</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>